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Abstract
The highly pathogenic Old World arenavirus Lassa virus (LASV) and the prototypic arenavirus lymphocytic choriomeningitis
virus (LCMV) use a-dystroglycan as a cellular receptor and enter the host cell by an unusual endocytotic pathway
independent of clathrin, caveolin, dynamin, and actin. Upon internalization, the viruses are delivered to acidified endosomes
in a Rab5-independent manner bypassing classical routes of incoming vesicular trafficking. Here we sought to identify
cellular factors involved in the unusual and largely unknown entry pathway of LASV and LCMV. Cell entry of LASV and LCMV
required microtubular transport to late endosomes, consistent with the low fusion pH of the viral envelope glycoproteins.
Productive infection with recombinant LCMV expressing LASV envelope glycoprotein (rLCMV-LASVGP) and LCMV depended
on phosphatidyl inositol 3-kinase (PI3K) as well as lysobisphosphatidic acid (LBPA), an unusual phospholipid that is involved
in the formation of intraluminal vesicles (ILV) of the multivesicular body (MVB) of the late endosome. We provide evidence
for a role of the endosomal sorting complex required for transport (ESCRT) in LASV and LCMV cell entry, in particular the
ESCRT components Hrs, Tsg101, Vps22, and Vps24, as well as the ESCRT-associated ATPase Vps4 involved in fission of ILV.
Productive infection with rLCMV-LASVGP and LCMV also critically depended on the ESCRT-associated protein Alix, which is
implicated in membrane dynamics of the MVB/late endosomes. Our study identifies crucial cellular factors implicated in Old
World arenavirus cell entry and indicates that LASV and LCMV invade the host cell passing via the MVB/late endosome. Our
data further suggest that the virus-receptor complexes undergo sorting into ILV of the MVB mediated by the ESCRT,
possibly using a pathway that may be linked to the cellular trafficking and degradation of the cellular receptor.
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Introduction
Over the past decades, several arenaviruses have emerged as
causative agents of severe viral hemorrhagic fevers (VHF) that
belong to the most devastating human diseases [1]. The Old World
arenavirus Lassa virus (LASV) is the most prevalent human
pathogen among the arenaviruses, causing several hundred
thousand infections per year in Africa with thousands of deaths
[2,3]. The fatality rate of Lassa fever in hospitalized patients is
.15% [4], rising to more than 50% in some outbreaks [5]. There is
currently neither an efficient cure nor an efficacious vaccine,
making LASV arguably one of the most neglected tropical
pathogens.Theprototypicarenaviruslymphocyticchoriomeningitis
virus (LCMV) merits significant attention as a powerful tractable
experimental model system to study virus-host interactions and also
as a prevalent human pathogen of clinical significance in congenital
infections [6,7,8]. Moreover, LCMV infection of immunosup-
pressed adults can result in severe disease and death [9,10].
Arenaviruses are enveloped negative strand RNA viruses with a
non-lytic life cycle. The genome of LASV consists of two single-
stranded RNA species, a large segment encoding the virus
polymerase (L) and a small zinc finger motif protein (Z), and a
small segment encoding the virus nucleoprotein (NP) and
glycoprotein precursor (GPC) [11]. GPC is processed into GP1,
implicated in receptor binding, and the transmembrane GP2,
which contains the viral fusion machinery, allowing fusion of the
viral and the cellular membrane during viral entry.
Binding of a virus to its cellular receptor(s) and subsequent entry into
target cells are the first steps of virus infection and a fundamental aspect
of the virus-host cell interaction [12,13]. The first cellular receptor for
Old World arenaviruses was identified as a-dystroglycan (a-DG), the
peripheral moiety of DG, a highly conserved and ubiquitously
expressed cell surface receptor for extracellular matrix (ECM) proteins
[14]. Initially encoded as a single polypeptide, DG is cleaved into the
extracellular a-DG and membrane anchored b- D G[ 1 5 ] .D Gi s
expressed in most cells of developing and adult tissues and provides a
molecular link between the ECM and the actin-based cytoskeleton.
Alpha-DG is a primary receptor for LASV, most isolates of LCMV,
the African arenaviruses Mopeia and Mobala, as well as Clade C New
World arenaviruses [14,16].
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are delivered to acidified endosomes where pH-dependent fusion
between the viral and the cellular membrane occurs [17]. The pH
optimum for LCMV and LASV fusion of ,5.0 is remarkably low
[18] suggesting fusion in a late endosomal compartment. Electron
microscopic examination of LCMV entry demonstrated uptake of
virions in smooth vesicles lacking a clathrin coat [17,19]. LCMV
and LASV enter cells predominantly via an unusual pathway of
endocytosis that shows some dependence on membrane choles-
terol [20], but is independent of clathrin and caveolin, and does
not require dynamin, ARF6, flotillin, or actin [19,20,21].
Receptor-mediated endocytosis of LCMV and LASV occurs
rapidly with pH-dependent fusion occurring after 16–20 minutes
[19,21], a kinetics similar to viral entry via clathrin-mediated
endocytosis [22]. Remarkably, endosomal trafficking of LCMV
and LASV was only mildly affected by dominant negative (DN)
mutants of the small GTPase Rab5, involved in vesicular
trafficking from the plasma membrane to the early endosome,
and DN Rab7, which is implicated in delivery from early to late
endosomes [19,21]. Here we sought to identify cellular factors
involved in cell entry and endosomal trafficking of LASV and
LCMV.
Results
Cell entry of LASV and LCMV depend on microtubular
transport
The low fusion pH of LASV and LCMV [18] suggests that the
fusion event occurs in a late endosomal/lysosomal compartment.
Since late endosomal compartments are located in the perinuclear
area of the cell distant from the plasma membrane, delivery of
vesicles to late endosomes is frequently facilitated by the cell’s
microtubular transport systems [12]. Depolymerization of micro-
tubules by nocodazole results in accumulation of endocytosed
cargo beyond early endosomes, but before late endosomes.
Previous experiments demonstrated that nocodazole treatment
markedly reduced infection of cells with LCMV and recombinant
LCMV expressing the glycoprotein of LASV (rLCMV-LASVGP)
[21]. These studies reported an inhibitory effect of nocodazole on
early virus infection when the drug was added up to 60 minutes
after infection [21]. Since Old World arenaviruses escape from
endosomes already after circa 20 minutes [19,21], these studies
could not distinguish between effects of nocodazole on viral entry
and/or early replication. To specifically address the role of
microtubules in cell entry of LASV and LCMV prior to pH-
dependent membrane fusion, we exploited the fact that cytosolic
transport and replication of the nucleocapsid of vesicular stomatitis
virus (VSV) after fusion does not require microtubules [23]. Since
host cell attachment and entry of arenaviruses are mediated
exclusively by the viral GP, recombinant VSV pseudotyped with
arenavirus GPs allow separating arenavirus entry from subsequent
steps of replication of the VSV core.
Recombinant VSV, whose G protein has been replaced by a
GFP reporter (rVSVDG) [24] was pseudotyped with the GPs of
LASV and the LCMV isolate clone-13, henceforth referred to as
LCMV, as described [25]. The virion particles of VSV and
arenaviruses differ significantly in size and shape. Old World
arenaviruses are pleomorphic particles ranging in size from 40–
200 nm [11], whereas the rhabdovirus VSV has a characteristic
bullet shape with a length of circa 180 nm and a width of 80 nm
[26]. Previous studies showed that pseudotyping of VSV with
arenavirus GPs preserved the bullet-shape of the VSV core [27].
Since the shape of virions may significantly affect the pathway of
cell entry, we wanted to ensure that cell entry of the VSV
pseudotypes rVSVDG-LASVGP and rVSVDG-LCMVGP still
followed the unusual route of endocytosis described for LCMV
and LASV. For comparison, we used a VSV pseudotype bearing
the endogenous VSV G (rVSVDG-VSVG) that enters cells by
clathrin-mediated endocytosis (CME) [28] analogous to wild-type
VSV [29].
First, we compared the entry kinetics of rVSVDG-LASVGP,
rVSVDG-LCMVGP and rVSVDG-VSVG. To assess how fast
receptor-bound VSV pseudotypes trafficked to endosomes and
underwent membrane fusion, we determined the time required for
the viruses to become resistant to the lysosomotropic agent
ammonium chloride. When added to cells at a concentration of
20 mM, ammonium chloride raises the endosomal pH rapidly and
blocks low pH-dependent cellular processes without causing
overall cytotoxicity [30,31]. Viruses were added to A549 human
lung epithelial cells in the cold to allow receptor binding without
internalization. The temperature was rapidly shifted to 37uC and
20 mM ammonium chloride added at the indicated time points
and left throughout the experiment. After 12 hours cells were fixed
and infected cells expressing GFP quantified by flow cytometry. In
line with previous reports on VSV cell entry [29], 50% of
rVSVDG-VSVG reached insensitivity to ammonium chloride
after only 8–10 minutes (Fig. 1A). In contrast, rVSVDG-LASVGP
and rVSVDG-LCMVGP became insensitive to ammonium
chloride with a half-time of circa 20 minutes, consistent with the
entry kinetics of rLCMV-LASVGP [21] and LCMV [19].
To verify the use of distinct pathways of cell entry by rVSVDG-
LASVGP and rVSVDG-LCMVGP on the one hand and
rVSVDG-VSVG on the other hand, we used a combination of
pharmacological inhibitors, RNA interference (RNAi) and dom-
inant negative (DN) mutants of regulatory proteins of endocytosis.
Cell entry of LASV and LCMV is sensitive to drugs that deplete
membrane cholesterol, such as methyl-b-cyclodextrin (MbCD),
whereas VSV infection via CME is less sensitive [20,32,33]. Pre-
treatment with increasing concentrations of MbCD efficiently
depleted membrane cholesterol (Fig. 1B) and resulted in a dose-
dependent reduction of infection with rVSVDG-LASVGP and
rVSVDG-LCMVGP, but not rVSVDG-VSVG (Fig. 1C). Choles-
Author Summary
Old World arenaviruses include the prototypic lymphocytic
choriomeningitis virus (LCMV) and the highly pathogenic
Lassa virus (LASV) that causes a severe hemorrhagic fever
in humans and infects several thousand individuals per
year in Western Africa. Cell entry of a virus is the first step
of every virus infection and represents a promising target
for therapeutic intervention. We and others had shown
that LCMV and LASV attach to a cellular receptor, a-
dystroglycan, followed by internalization by endocytosis
via a novel and unusual pathway. Here we investigated the
largely unknown molecular mechanisms of cell entry of
LASV and LCMV with the goal to identify host cell factors
involved. We discovered that during cell entry LASV and
LCMV pass through a particular intracellular compartment,
the multivesicular body (MVB)/late endosome, which is
implicated in the internalization and degradation of
cellular membrane receptors. Productive infection of LASV
and LCMV critically depended on cellular factors involved
in the membrane dynamics and sorting processes in the
MVB. Based on our studies, we propose a model for Old
World arenavirus entry in which the viruses hijack a
pathway that may be linked to the cellular trafficking and
degradation of their cellular receptor.
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not imply a specific pathway of entry. To address the specific role
of CME in cell entry of the VSV pseudotypes, we depleted clathrin
heavy chain (CHC) in A549 cells by RNAi as described [21],
which resulted in .90% reduction of CHC protein levels after
48 hours as assessed by Western-blot (Fig. 1D). Subsequent
infection of CHC-depleted cells revealed a significant reduction
of infection with rVSVDG-VSVG, but not rVSVDG-LASVGP
and rVSVDG-LCMVGP, consistent with the clathrin-indepen-
dent cell entry of LASV and LCMV (Fig. 1D). As a
complementary approach, we performed inhibition studies using
chlorpromazine (CPZ), a drug that perturbs the assembly of
clathrin-coated pits at the plasma membrane and inhibits CME.
Treatment of A549 cells with up to 8 mM CPZ did not
significantly affect infection with rVSVDG-LASVGP and
rVSVDG-LCMVGP, but lead to a dose-dependent reduction of
rVSVDG-VSVG infection (Fig. 1E). In addition we employed
well-characterized dominant-negative (DN) mutants for regulatory
proteins associated with CME, including a DN form of the
clathrin-coat associated protein Eps15 (Eps15D95/295), which
selectively perturbs CME without affecting clathrin-independent
pathways [34,35], and the DN mutant K44A of dynamin II
[36,37,38]. The effects of the DN mutants on pseudotype infection
were assessed as reported [21]. Briefly, HEK293 cells were
transfected with GFP-tagged versions of the wild-type or DN
mutants by nucleofection resulting in .90% transfected cells.
Figure 1. Recombinant VSV pseudotypes adopt the cell entry characteristics of LASV and LCMV. (A) Entry kinetics of rVSVDG-LASVGP,
rVSVDG-LCMVGP, and rVSVDG-VSVG. A549 cells were seeded in 96 well plates (10
4 cells/well) and cultured for 16 hours. The resulting cell monolayers
were chilled on ice and the indicated pseudotypes added at MOI of 3 for 1 hour. Unbound virus was removed and cells quickly shifted to 37uC. At the
indicated time points 20 mM ammonium chloride (NH4Cl) was added and left throughout the experiment. After a total of 12 hours, cells were
detached, fixed, and infection detected by the GFP reporter in flow cytometry. Data presented show percent GFP positive cells. Means (n=36SD). (B)
Depletion of membrane cholesterol by MbCD. Monolayers of A549 cells were incubated with the indicated concentrations of MbCD for one hour and
total cholesterol determined in a colorimetric assay. Shown are two independent experiments in triplicates expressed in percent of untreated control
(mean 6 SD). (C) Cholesterol depletion reduces infection with rVSVDG-LASVGP, rVSVDG-LCMVGP, but not rVSVDG-VSVG. A549 cells (10
4 cells/well)
were treated with the indicated concentrations of MbCD as in (B), followed by infection with 200 PFU of rVSVDG-LASVGP (LASVGP), rVSVDG-LCMVGP
(LCMVGP), and rVSVDG-VSVG (VSVG) per well. Infection was assessed after 12 hours by detection of GFP expressing cells in fluorescence microscopy
(mean 6 SD; n=3). (D) Infection with rVSVDG-LASVGP and rVSVDG-LCMVGP does not depend on clathrin. A549 cells were transfected with either a
pool of siRNA targeting clathrin heavy chain (CHC) (50 nM per siRNA; 200 nM total concentration) or control siRNA (200 nM). After 48 hours, cells
were lysed and expression of CHC assessed by Western-blot. For normalization, a-tubulin (a-Tu) was detected. Cells transfected with siRNA to either
CHC or control siRNAs (Control) for 48 hours were infected with 200 PFU of rVSVDG-LASVGP (LASVGP), rVSVDG-LCMVGP (LCMVGP), and rVSVDG-
VSVG (VSVG) per well. After 12 hours, cells were fixed and infection assessed by detection of GFP as in (C) (mean 6 SD; n=3). (E) Infection with
arenavirus pseudotypes is not sensitive to chlorpromazine (CPZ). A549 cells were pre-treated with the indicated concentrations of CPZ for 2 hours,
followed by infection with rVSVDG-LASVGP (LASVGP), rVSVDG-LCMVGP (LCMVGP), and rVSVDG-VSVG (VSVG) at MOI of 3. After 12 hours, infection
was assessed as in (A) (mean 6 SD; n=3). (F) Comparison of the effects of DN mutants of Eps15, dynamin II, and Rab5 on infection with VSV
pseudotypes. HEK293 cells were transfected with GFP-tagged DN and wild-type (WT) Eps15, dynamin II, and Rab5 using nucleofection, resulting in
.90% transfection efficiency, as assessed by detection of GFP. After 24 hours, cells were infected with rVSVDG-LASVGP (LASVGP), rVSVDG-LCMVGP
(LCMVGP), and rVSVDG-VSVG (VSVG) at 200 PFU/well. Infected cells were detected by IFA using a mAb to VSV M protein and a rhodamine-red-X
conjugated secondary antibody. Specimens were examined using a fluorescence microscope with a narrow band-pass filter and VSV M positive cells
scored (mean 6 SD; n=3).
doi:10.1371/journal.ppat.1002232.g001
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pseudotypes. At 12 hours p.i., cells were fixed and infected cells
detected by immunofluorescence assay (IFA) using an antibody to
the VSV M protein. As shown in Fig. 1F, expression of DN Eps15
and dynamin II markedly reduced infection with rVSVDG-
VSVG, but not the arenavirus pseudotypes. Another hallmark of
LASV and LCMV cell entry is independence from Rab5 [19,21],
which is implicated in incoming vesicular trafficking from the
plasma membrane to the early endosome [39,40]. HEK293 cells
were transfected with GFP-tagged constructs expressing wild-type
and DN Rab5. Twenty hours later, cells were infected with VSV
pseudotypes and infection assessed after 12 hours. In line with
previous studies, infection with rVSVDG-LASVGP and rVSVDG-
LCMVGP was only slightly affected by DN Rab5, whereas
infection with rVSVDG-VSVG was significantly reduced. In sum,
the data confirm that rVSVDG-LASVGP and rVSVDG-
LCMVGP enter cells via a cholesterol-dependent, clathrin-, and
dynamin- independent pathway characteristic for cell entry of
LASV and LCMV and bypasses Rab5-dependent transport to
early endosomes. This makes our VSV pseudotypes suitable to
address the specific role for microtubules and other cellular factors
in LASV and LCMV cell entry.
To verify independence of cytosolic transport and replication of
the VSV nucleocapsid from microtubules, we artificially induced
fusion directly at the plasma membrane. For this purpose, the
VSV pseudotypes were attached to cells in the cold, unbound virus
removed, and cells rapidly shifted to 37uC, immediately followed
by exposure to acidified medium (pH=5.0). After 15 minutes,
cells were washed with neutral medium and virus infection
determined 12 hours later by detection of the GFP reporter in flow
cytometry. Consistent with published data [23], fusion of VSV
pseudotypes at the plasma membrane resulted in relatively
inefficient infection (,10% of normal infection levels) that was
insensitive to nocodazole (Fig. 2A). When allowed to enter via their
normal routes, infection of all pseudotypes was significantly
affected by nocodazole (Fig. 2A), although to a different extent.
Infection with rVSVDG-LASVGP and rVSVDG-LCMVGP was
reduced by circa 80%, whereas infection with rVSVDG-VSVG
was less affected. The effect of nocodazole on infection with
rVSVDG-LASVGP and rVSVDG-LCMVGP suggests that infec-
tion via the normal route involves microtubular transport to late
endosomes where pH-dependent fusion occurs. The observed
dependence of rVSVDG-VSVG on microtubules is in line with
previous reports that demonstrated a requirement for late
endosomes transport for optimal VSV infection [23]. The
significantly stronger effect of nocodazole on the arenavirus
pseudotypes when compared to rVSVDG-VSVG (Fig. 2A) may be
explained by the fact that the G of VSV has a fusion pH of .6.0,
allowing at least partial fusion and exit of the virus at the level of
the early endosome, whereas LASVGP and LCMVGP cannot
undergo fusion before reaching the more acidic late endosome.
LASV and LCMV entry depends on phosphatidylinositol
3-phosphate (PI3P) and lysobisphosphatidic acid (LBPA)
In the host cell, receptor proteins at the plasma membrane can
be internalized and delivered to late endosomes/lysosomes via
specialized endosomal compartments called multivesicular bodies
(MVB) [41]. In the MVB, receptor proteins destined for transport
to late endosomes are sorted into intraluminal vesicles (ILV) that
give the organelle its particular multivesicular morphology.
Sorting into ILV is mediated by a large supramolecular complex,
the endosomal sorting complex required for transport (ESCRT)
[41]. In a first attempt to address a possible role of the MVB in
LASV and LCMV cell entry, we interfered with the synthesis of
the lipid phosphatidylinositol 3-phosphate (PI3P), which is
required for formation of functional MVBs [41]. Perturbation of
MVB formation by treatment of cells with inhibitors of PI3 kinase
(PI3K) does not affect infection with VSV [23], because VSV can
undergo fusion at the early endosome and subsequent cytosolic
transport and replication is independent of PI3K. To assess a
possible effect of PI3K inhibition on LASV and LCMV cell entry
we therefore employed again our VSV pseudotypes. As expected,
addition of the PI3K inhibitor wortmannin (100 nM) had no
significant effect of VSV pseudotype infection when fusion was
induced at the plasma membrane (Fig. 2B). To study the effect of
wortmannin on infection via the normal entry route, VSV
pseudotypes were attached to A549 cells in the cold followed by
a temperature shift to 37uC to allow internalization. To address
the effect of wortmannin selectively on endosomal transport, but
not internalization of the virus particles, the fast-acting drug was
added 5 minutes after the temperature shift, a time point when
most of the virus is already present in vesicles [17,19]. While
wortmannin slightly enhanced infection with rVSVDG-VSVG,
consistent with published data [23], infection with the arenavirus
pseudotypes was significantly reduced (Fig. 2B), indicating that
PI3K activity is required for efficient cell entry of LASV and
LCMV pseudotypes.
Another, more specific component involved in protein and lipid
sorting through the MVB is the phospholipid lysobisphosphatidic
acid (LBPA) that is found in late endosomes, in particular in the
membrane of ILV, and is crucial for the ILV formation [42]. To
address the role of LBPA in LASV and LCMV cell entry, we used
the function-blocking monoclonal antibody (mAb) 6C4 to LBPA
[42]. Pre-treatment of cells with anti-LPBA antibody allows uptake
by fluid-phase endocytosis with accumulation in late endosomes
[23]. A549 cells were treated with anti-LBPA antibody or an
isotype (IgG1) control and subsequently infected with VSV
pseudotypes of LASV and LCMV. As a positive control, we used
VSV pseudotypes bearing VSVG, whose infection is perturbed by
anti-LBPA treatment [23]. For comparison, we included a
replication-deficient recombinant human species C adenovirus
serotype 5 expressing EGFP (AdV5-EGFP) [43], which naturally
infects human lung epithelial cells, such as A549 cells [44]. In
contrast to Old World arenaviruses, human species C adenovi-
ruses (AdV2, AdV5) use the Coxsackie virus B adenovirus receptor
(CAR) and integrins for host cell attachment and are internalized
via a clathrin-dependent pathway [45]. Upon internalization,
AdV2 and AdV5 are delivered to early endosomes and rapidly
penetrate into the cytoplasm by a complex mechanism including
low pH, interaction of the AdV penton base protein with avb5
integrins, integrin signaling, and activity of a viral protease [45].
To exclude a direct anti-viral effect of the antibody per se, untreated
cells were incubated with the viruses for 1 h at 4uC in presence of
the antibody, unbound virus washed out, and cell incubated at
37uC in absence of the antibody. As shown in Fig. 3A, pre-
treatment of cells with anti-LBPA specifically reduced subsequent
infection with VSV pseudotypes of LASV, LCMV, and VSV, but
not AdV5-EGFP. Treatment of the virus with anti-LBPA antibody
had no effect on subsequent infection.
Next, we sought to verify our findings with live arenaviruses. To
circumvent biosafety restrictions associated with LASV, we studied
LASV entry using a recombinant LCMV expressing LASV GP
(rLCMV-LASVGP). Since LASV cell entry is mediated exclusively
by the viral GP, rLCMV-LASVGP can be used as a BSL2
surrogate to study LASV cell entry in the context of a productive
arenavirus infection [21]. A549 cells were pre-treated with anti-
LBPA antibody as described above, followed by infection with
rLCMV-LASVGP, LCMV, VSV, and AdV5-EGFP. To prevent
Old World Arenaviruses Cell Entry
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20 mM ammonium chloride at 4 hours after infection. Cells
infected with rLCMV-LASVGP, LCMV, and AdV5-EGFP were
fixed after 16 hours and cells infected with VSV after 6 hours.
Infection with rLCMV-LASVGP and LCMV was detected by
immunofluorescence assay (IFA) using antibodies to the LCMV
nucleoprotein (NP) and VSV infection was detected by immuno-
staining with an antibody to the matrix (M) protein. Similar to our
findings with the VSV pseudotypes, treatment with anti-LBPA
antibody resulted in significant reduction of infection with
rLCMV-LASVGP and LCMV, but not AdV5-EGFP (Fig. 3B).
Remaining infected cells in cultures pre-treated with anti-LBPA
showed normal morphology and expression levels of viral NP
(Fig. 3C), excluding overt toxicity of antibody treatment. To
further exclude a non-specific effect of anti-LBPA on endocytosis,
we assessed the impact of anti-LBPA on the uptake of transferrin,
which involves CME followed by delivery to the early endosome,
but does not implicate the MVB/late endosome. Cells pre-treated
with anti-LBPA showed normal internalization of transferrin
(Fig. 3D) excluding general perturbation of endocytosis and
membrane dynamics by the anti-LBPA antibody. In sum, the
dependence of rLCMV-LASVGP and LCMV cell entry and
productive infection on PI3K and LBPA provided the first hints
that, upon internalization, the virus-receptor complex may
undergo sorting in the MVB/late endosome.
Cell entry of LASV and LCMV involves the ESCRT
components Hrs, Tsg101, Vps22, and Vps24
Sorting of cargo into ILV membranes of the MVB involves the
initial recognition of cargo by the ESCRT-0 protein Hrs, which
results in sequential assembly of ESCRT-I, ESCRT-II, and
ESCRT-III complexes, followed by vesicle formation [41]. In a
first step to investigate the role of the ESCRT for LASV and
LCMV entry, we performed RNAi silencing for selected
components of the different ESCRT sub-complexes: the
ESCRT-0 component Hrs, the pivotal ESCRT-I protein
Tsg101, and the proteins Vps22 and Vps24 that are crucial
components of ESCRT-II and ESCRT-III, respectively. Hrs
regulates MVB formation by recruiting the ESCRT to endosomes
[46] and Tsg101 is a crucial component of the ESCRT involved in
sorting of cargo into ILV, as well as ILV formation [47,48]. Vps22
and Vps24 have been implicated in endosomal sorting and
degradation of cellular membrane receptors [49,50]. For RNAi
silencing, firmly established and validated siRNA sequences to
human Hrs, Tsg101, Vps22, and Vps24 were used (for details see
Methods). Silencing of Hrs and Tsg101 in A549 cells by specific
siRNAs resulted in efficient depletion of the endogenous proteins
as assessed by Western-blot (Fig. 4A). Due to the lack of specific
antibodies to Vps22 and Vps24, the efficiency of RNAi was
verified by quantitative PCR that revealed .90% reduction in
mRNA levels after 72 hours (Fig. 4B).
To assess their role in LASV and LCMV cell entry, A549 cells
were treated with siRNAs to Hrs, Tsg101, Vps22, Vps24, and a
control siRNA. After 72 hours, cells were infected with VSV
pseudotypes of LASV and LCMV, VSV pseudotypes bearing
VSVG, and AdV5-EGFP. To exclude possible effects of the
siRNA treatment on the cytoplasmic transport and/or replication
of the VSV core, we included a series in which fusion of VSV
pseudotypes was induced at the plasma membrane as described
above. Upon fusion at the plasma membrane, infection of the
VSV pseudotypes was unaffected by siRNA treatment (Fig. 4C),
excluding adverse effects of RNAi on VSV replication at a post-
entry step. Next, we infected siRNA treated cells via the normal
route of cell entry. Although Tsg101 has previously been
implicated in budding of arenaviruses [51], this was not a concern
in our experimental setup, as VSV pseudotypes are replication-
deficient, preventing secondary infection. After 16 hours of
infection, cells were fixed and infection assessed by detection of
Figure 2. The role of microtubules and PI3K in cell entry of LASV and LCMV. (A) LASV and LCMV cell entry depend on microtubules. A549
cells (10
4 cells/well) in 96 well plates were pre-treated with 10 mM nocodazole (Noc) for 1 hour, chilled on ice and incubated with rVSVDG-LASVGP
(LASVGP), rVSVDG-LCMVGP (LCMVGP), and rVSVDG-VSVG (VSVG) at MOI of 1 for one hour in the cold. Unbound virus was removed and cells shifted
to 37uC in presence of nocodazole. To induce fusion at the plasma membrane, cells were pulsed with acidified medium (pH 5.0) for 15 minutes,
followed by immediate neutralization. Cells subjected to normal infection were cultured in parallel, without applying the low pH pulse. After a totalo f
12 hours, infection assessed by detection of GFP expressing cells in flow cytometry as in Fig. 1A (mean 6 SD; n=3). (B) A role of PI3K in cell entry of
LASV and LCMV. A549 cells were incubated with rVSVDG-LASVGP (LASVGP), rVSVDG-LCMVGP (LCMVGP), and rVSVDG-VSVG (VSVG) at MOI of 1 for
one hour in the cold and unbound virus removed. Cells were shifted to 37uC and fusion at the membrane was induced with a low pH pulse with
acidified medium (pH 5.0) for 15 minutes. After neutralization, cells were cultured for a total of 12 hours in presence of 100 nM wortmannin. Cells
subjected to normal infection were pre-incubated with virus in the cold. After removal of unbound virus, cells were rapidly shifted to 37uC for
5 minutes to allow internalization of the virus. Wortmannin was then added (100 nM) and left throughout the experiment. Infection was determined
by detection of GFP expressing cells by flow cytometry as in Fig. 1A (mean 6 SD; n=3).
doi:10.1371/journal.ppat.1002232.g002
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depletion of Hrs, Tsg101, Vps22, and Vps24 resulted in significant
reduction in numbers of infected cells with VSV pseudotypes of
LASV, LCMV, and VSV (Fig. 4D). In contrast, infection with
AdV5-EGFP was only mildly affected by depletion of Tsg101 and
Vps22, whereas silencing of Hrs and Vps24 enhanced infection
(Fig. 4D). Since depletion of Hrs, Tsg101, Vps22, and Vps24 did
not affect post entry-steps of VSV infection (Fig. 4C) the data
suggest a role for these ESCRT components in cell entry of
pseudotypes of LASV and LCMV. To validate our results with
arenaviruses, A549 cells were subjected to siRNA treatment,
followed by infection with rLCMV-LASVGP and LCMV, using
VSV pseudotypes bearing VSVG and AdV5-EGFP as positive
and negative controls, respectively. Since Tsg101 has previously
been implicated in budding of arenaviruses [51], we addressed the
effect of the knockdowns on viral entry by blocking secondary
infection with 20 mM ammonium chloride added at 4 hours post
infection. After 16 hours of infection, cells were fixed and infected
cells detected by IFA using antibodies to LCMV NP. Consistent
with the results obtained with VSV pseudotypes (Fig. 4D),
depletion of Hrs, Tsg101, Vps22, and Vps24 resulted in significant
reduction of the numbers of infected cells with all viruses, except
AdV5-EGFP (Fig. 4E). In cultures treated with siRNAs specific to
Hrs, Tsg101, Vps22, and Vps24 residual infected cells had similar
expression levels of LCMV NP as observed in cells treated with
control siRNA (Fig. 4F), indicating that the siRNA treatment did
not affect post-fusion steps of early replication. To exclude
unspecific off-target effects on membrane dynamics and endocy-
tosis, cells subjected to RNAi for Hrs, Tsg101, Vps22, and Vps24
were tested for transferrin uptake. None of the RNAi treatments
Figure 3. Cell entry of LASV and LCMV depends on LBPA. (A) Infection of VSV pseudotypes of LASV, LCMV, and VSV is affected by anti-LBPA
antibody. A549 cells (10
4 cells/well) in 96 well plates were pre-incubated with no antibody (1), 50 mg/ml mAb anti-LBPA (2) or isotype antibody
control (3) for 14 hours. Cells were then infected with rVSVDG-LASVGP (LASV), rVSVDG-LCMVGP (LCMV), and rVSVDG-VSVG (VSV), and AdV5-EGFP at
500 PFU/well. In specimens subjected to pretreatment only (4), the cells were incubated for 1 h at 4uC with viruses in presence of the Ab, unbound
virus washed out, and cell incubated at 37uC in normal medium. Cells were fixed after 16 hours and EGFP positive cells counted (mean 6 SD; n=3).
(B) Anti-LBPA perturbs infection of rLCMV-LASVGP and LCMV. Monolayers of A549 cells were treated as in (A), followed by infection with rLCMV-
LASVGP, LCMV, and AdV5-EGFP (AdV) at 500 PFU/well. Cells were fixed after 16 hours (rLCMV-LASVGP, LCMV, VSV, or AdV5-EGFP) and 6 hours (VSV).
Infection was detected with a mAb to LCMV NP (rLCMV-LASVGP, LCMV), VSV M protein (VSV), or EGFP (AdV5-EGFP) (mean 6 SD; n=3). (C)
Representative specimens of cells infected with rLCMV-LASVGP in (B) LCMV NP is in red and nuclei (DAPI) appear in blue. Bar=50 mm. (D) Anti-LBPA
treatment does not interfere with transferrin uptake. Cells treated as in (A) were incubated for 10 min at 37uC with serum-free medium containing
20 mg/ml of Alexa594-labeled human transferrin, washed with ice cold PBS, acid-stripped to remove surface-bound transferrin, fixed, and the cellular
distribution of transferrin (red) examined. Cell nuclei are stained in blue with DAPI (bar=10 mM).
doi:10.1371/journal.ppat.1002232.g003
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excluding a general impact on endocytosis (Fig. 4G). Since
perturbation of the ESCRT machinery may affect cellular
trafficking of the Old World arenavirus receptor, we verified the
cell surface expression of a-DG. Cells subjected to RNAi were
examined by cell surface staining with mAb IIH6 that specifically
Figure 4. A role for Hrs, Tsg101, Vps22, and Vps24 in cell entry of LASV and LCMV. (A) A549 cells were transfected with siRNAs specific for
Hrs and Tsg101 or control siRNA and efficiency of depletion assessed after 72 hours by Western-blot. For normalization, a-tubulin (a-Tu) was used. (B)
Cells were transfected with siRNAs for Vps22 and Vps24 or control siRNA and efficiency of depletion assessed after 72 hours by quantification of
mRNA levels by RT-qPCR (for details see Methods). Given are normalized levels of mRNA expression. (C) Depletion of Hrs, Tsg101, Vps22, and Vps24
does not affect post-entry steps of VSV pseudotype infection. A549 cells were treated with specific siRNAs to Hrs, Tsg101, Vps22, and Vps24 and
control siRNA for 48 hours. Cells were then detached and reseeded in 96 well plates (10
4 cells/well). After 24 hours, cells were incubated with
rVSVDG-LASVGP (LASV) (4000 PFU/well), rVSVDG-LCMVGP (LCMV) (4000 PFU/well), and rVSVDG-VSVG (VSV) (2000 PFU/well) in the cold, followed by
washing and a low pH pulse to induce fusion at the plasma membrane as in Fig. 2. Upon neutralization, cells were fixed after 16 hours and EGFP
positive cells scored (mean 6 SD; n=3). (D, E) Depletion of Hrs, Tsg101, Vps22, and Vps24 affects cell entry of LASV and LCMV. Cells subjected to RNAi
silencing as in (A) were infected via the normal route of entry (D) with rVSVDG-LASVGP (LASV), rVSVDG-LCMVGP (LCMV), rVSVDG-VSVG (VSV), and
AdV5-EGFP (AdV) (500 PFU/well) and (E) with rLCMV-LASVGP, LCMV, rVSVDG-VSVG (VSV), and AdV5-EGFP (AdV) at 500 PFU/well. After 16 hours, cells
were fixed and infection quantified by detection of EGFP positive cells (D) or LCMV NP and EGFP (E) as in Fig. 3 (mean 6 SD; n=3). (F) Representative
specimens of rLCMV-LASVGP infected cells in cultures treated with the indicated siRNAs in (E). LCMV NP is stained in green and cell nuclei stained
with DAPI appear in blue (bar=20 mM). (G) Depletion of Hrs, Tsg101, Vps22, and Vps24 by RNAi does not interfere with transferrin uptake. Cells were
treated as in (A, B) and transferrin uptake assessed as in Fig. 3D. Transferrin is in red and cell nuclei in blue (bar=10 mM). (H) Depletion of Hrs, Tsg101,
Vps22, and Vps24 by RNAi does not affect cell surface expression of a-DG. Cells were subjected to RNAi as in (A, B). After 72 hours cell surface staining
was performed with mAb IIH6 to a-DG, combined with Alexa 594 secondary antibody. Data were acquired in a FACSCalibur flow cytometer and
analyzed using Cell Quest software. In histograms, y-axis represents cell numbers and x-axis Alexa 594 fluorescence intensity. Shaded area: primary
and secondary antibody, empty area: secondary antibody only. The broken line indicates the superimposition of the shaded peak (primary+secondary
antibody) from cells treated with control siRNA. Note that treatment with siRNAs to Hrs, Tsg101, Vps22, and Vps24 does not significantly alter the
mean fluorescence intensity of the IIH6 signal.
doi:10.1371/journal.ppat.1002232.g004
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receptor [52]. As shown in Fig. 4H, depletion of Hrs, Tsg101,
Vps22, and Vps24 did not affect the cell surface levels of functional
a-DG in A549 cells.
To confirm the role of Tsg101 on LASV and LCMV cell entry
in a complementary manner, we overexpressed recombinant
Tsg101 and assessed the impact on the infection kinetics by
ammonium chloride treatment, as described above. For over-
expression studies, a high transfection efficiency of .80% was
needed. As A549 cells were difficult to transfect, with transfection
efficiencies of ,40%, we used HEK293 cells for these studies.
Depletion of Hrs, Tsg101, Vps22, and Vps24 in HEK293 affected
infection with rLCMV-LASVGP and LCMV in a similar manner
as observed in A549 cells (data not shown). Briefly, HEK293 cells
were transfected with an expression plasmid encoding a recom-
binant MYC-tagged form of Tsg101 or empty vector, resulting in
significant over-expression of Tsg101 (Fig. 5A). After 36 hours,
cells were incubated with rLCMV-LASVGP in the cold, unbound
virus removed, and the temperature shifted to 37uC. At different
time points 20 mM ammonium chloride was added and virus
infection detected after a total of 16 hours by intracellular staining
for LCMV NP and flow cytometry. Over-expression of Tsg101
significantly shortened the half time by which the virus infection
became insensitive to ammonium chloride (Fig. 5B). However, the
total number of infected cells was only slightly increased (Fig. 5B),
indicating a selective acceleration of the viral entry process.
Consistent with the data obtained in A549 cells (Fig. 4E), depletion
of Tsg101 by RNAi markedly reduced the number of infected cells
(Fig. 5C). The faster apparent kinetics of viral entry upon Tsg101
overexpression further supports a role of this ESCRT-I protein as
a positive regulator for Old World arenavirus entry.
rLCMV-LASVGP and LCMV infection involves the ESCRT-
associated ATPase Vps4
To further investigate a possible role of ILV in rLCMV-
LASVGP and LCMV cell entry, we targeted the ESCRT-
associated ATPase Vps4 A and B, which are implicated in the final
step of the fission of ILV in MVBs in mammalian cells [41]. To
this end we employed an ATP hydrolysis DN mutant of Vps4A,
Vps4AEQ, which interferes with the formation of functional Vps4
oligomers and perturbs the formation of ILV mediated by both
Vps4A and B [53,54,55]. HEK293 cells were transfected with
FLAG-tagged versions of wild-type Vps4A and the DN mutant,
resulting in comparable levels of expression detected in Western-
blot (Fig. 6A). Thirty-six hours post transfection cells were infected
with rLCMV-LASVGP and LCMV. Since Vps4 has been
identified as a cellular factor required for arenavirus budding
[56], we again added 20 mM ammonium chloride at 4 hours p.i.
to prevent secondary infection. At 16 hours post infection, cells
were fixed and analyzed by FACS for viral antigen expression.
Live cells expressing similar levels of the FLAG-tagged wild type
and DN mutants were selected and those expressing viral antigen
scored (Fig. 6B). Over-expression of DN Vps4A, but not the wild-
type control resulted in a specific reduction of infection with
rLCMV-LASVGP and LCMV (Fig. 6C). Together, our data
provide the first evidence that cell entry of rLCMV-LASVGP and
LCMV requires a functional MVB.
Incoming LCMV transiently co-localizes with Tsg101 prior
to delivery to late endosomes
Using a combination of RNAi and recombinant proteins we
provided first evidence for a role of the ESCRT in cell entry of the
Old World arenaviruses LASV and LCMV. To corroborate these
findings, we performed co-localization studies of the prototypic
LCMV with Tsg101, which represents a key component of
ESCRT-I implicated in recognition of cargo, as well as Rab7, used
as a marker for late endosomes. For our co-localization
experiments, purified virus had to be used at high MOI. Based
on its better in vitro growth properties, we used the LCMV isolate
WE54 for these studies. LCMV WE54 had been used for the
initial characterization of the LCMV cell entry pathway [19] and
shares the receptor binding characteristics and entry pathway of
LCMV cl-13 and LASV [20]. LCMV WE54 was grown in large
quantities in BHK21 cells and purified by ultracentrifugation on a
renografin gradient as described [57]. To investigate whether
incoming LCMV co-localized with Tsg101, A549 cells were
Figure 5. Overexpression of Tsg101 accelerates entry kinetics of rLCMV-LASVGP. (A) Over-expression of a MYC-tagged recombinant
Tsg101 by transient transfection of HEK293 cells. Cells were transfected with recombinant Tsg101 (Tsg101) or empty vector (control). After 36 hours
total cell lysates were probed by Western-blot with antibodies recognizing Tsg101 or the MYC epitope. The MYC-tagged form of Tsg101 runs at a
slightly higher apparent molecular mass, due to the presence of the tag (*). (B) Overexpression of Tsg101 accelerates the entry kinetics of rLCMV-
LASVGP. Cells transfected with recombinant Tsg101 (Tsg101) or empty vector (Control) as in (A) were cooled on ice for 30 min and rLCMV-LFVGP
added at an MOI of 3. After incubation for 1 h on ice, unbound virus was washed off, and cells shifted to 37uC. At different time points, medium
containing 20 mM ammonium chloride was added. After a total of 16 h, cells were fixed and LCMVNP detected by intracellular staining with mAb 113
to LCMV NP, combined with Alexa 488-labeled secondary antibody. NP positive cells were quantified by flow cytometry as in Fig. 5D. Note the delay
in the fusion kinetics relative to Fig. 1A due to incubations of cells with ice cold medium after the washes. Data presented are means (n=3+SD). (C)
Entry kinetics in cells depleted of Tsg101. HEK293 cells were transfected with siRNA to Tsg101 or control siRNA as in Fig. 5A, resulting in .90%
reduction of Tsg101 protein expression after 72 hours (data not shown). Cells treated with siRNA for 72 hours were cooled on ice for 30 minutes and
rLCMV-LFVGP added at an MOI of 3. After removal of unbound virus entry kinetics was assessed as in (B). Data presented are means (n=3+SD).
doi:10.1371/journal.ppat.1002232.g005
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virus was removed and temperature shifted to 37uC. Cells were
fixed at different times and immunostaining performed. After mild
permeabilization of cells, incoming virus was detected with an
antibody to NP, labeling the virus RNP core. Endogenous Tsg101
was detected with a specific antibody. As a marker for late
endosomal compartments, we detected endogenous Rab7. Al-
though dominant negative Rab7 did not block cell entry of LCMV
and LASV [19,21], previous co-localization studies demonstrated
accumulation of LCMV in Rab7 positive compartment after
20 minutes, suggesting virus escape from late endosomes [19].
Specimens were examined by confocal laser scanning microscopy
and the co-localization of the virus with Tsg101 and Rab7 assessed
as described in Materials and Methods. As shown in Fig. 7, we
observed a transient co-localization of the virus with Tsg101 with a
maximum at 20 minutes after the temperature shift. At this early
time point co-localization of the virus with Rab7 was still weak
(Fig. 7B). At later time points, the co-localization between virus
and Tsg101 was gradually lost with a concomitant increase of co-
localization with Rab7 (Fig. 7B). The relatively low extent of co-
localization of LCMV with Tsg101 may be due to a transient
interaction of Tsg101 with the virus. Together, our data indicate
that incoming virus transiently passes through an MVB compart-
ment associated with Tsg101, and is then rapidly delivered to late
endosomes, consistent with sorting by the ESCRT.
LASV and LCMV cell entry depends on the ESCRT-
associated protein Alix
The apoptosis linked gene (ALG)-2-interacting protein X (Alix)
interacts with ESCRT proteins [58,59], is involved in endosomal
membrane dynamics in a LBPA-dependent manner [23,42,60],
membrane receptor endocytosis [61,62], and viral budding
[63,64,65]. To address the role of Alix in cell entry of LASV
and LCMV, we performed RNAi silencing of the protein in A549
cells using a validated siRNA to human Alix. Depletion of Alix by
the specific siRNA resulted in .90% reduction of Alix protein
levels after 72 hours, as assessed by Western-blot (Fig. 8A). Cells
depleted of Alix by RNAi were infected with VSV pseudotypes of
LASV, LCMV, and VSV as well as AdV5-EGFP. As shown in
Fig. 8B, depletion of Alix markedly reduced infection with all VSV
pseudotypes, but not AdV5-EGFP. When fusion was allowed at
the plasma membrane, depletion of Alix had no effect on post
entry replication of the VSV core (data not shown). The results
obtained with the VSV pseudotypes were validated with rLCMV-
LASVGP and LCMV (Fig. 8C). As observed with the RNAi
silencing of ESCRT proteins, depletion of Alix significantly
reduced the number of infected cells (Fig. 8C), but did not reduce
the expression levels of LCMV NP in remaining infected cells
(Fig. 8D). The efficient depletion of Alix did not cause overt
toxicity and had no significant effect on the uptake of transferrin
(Fig. 8E). Cell surface expression of functional a-DG was unaltered
(Fig. 8F). Similar effects of Alix depletion on infection with
rLCMV-LASVGP, LCMV, and VSV were observed in the
prototypic primate cell line CV-1 (data not shown), indicating a
role of Alix in rLCMV-LASVGP and LCMV cell entry in other
cell types.
An LCMV isolate independent of a-DG also depends on
ESCRT proteins for cell entry
While most strains and variants of LCMV use a-DG as a
cellular receptor, there exist LCMV isolates that can use
alternative receptors, different from a-DG [57,66]. The LCMV
isolates WE54 and WE22 differ from each other by only one point
mutation in GP1, S153 in WE54 and F153 in WE22. However,
the receptor use of WE54 and WE22 is strikingly different. Similar
to LCMV cl-13 and LASV, LCMV WE54 binds a-DG with high
affinity and depends on a-DG for cell entry, whereas WE 22 does
not bind to a-DG and infects cells in an a-DG-independent
manner [67]. The cellular receptor(s) of LCMV WE22 are
currently unknown, but initial characterization revealed that they
are either proteins or protein-associated structures [57]. Based on
their close structural relationship and strikingly different receptor
Figure 6. A role of Vps4 in rLCMV-LASVGP and LCMV entry. (A) HEK293 cells were transiently transfected with FLAG-tagged wild-type Vps4A
and the DN mutant Vps4AQE and expression of the recombinant proteins detected in Western-blot. (B) Expression of DN Vps4A reduced viral
infection. Cells were transiently transfected with FLAG-tagged wild-type and DN Vps4A. After 36 hours, cells were infected with rLCMV-LASVGP and
LCMV (MOI=1). After 16 hours, cells were fixed and stained for the Vps4A variants (anti-FLAG) and LCMV NP. Cells were analyzed by FACS separating
transfected ‘‘expressing’’ from untransfected ‘‘non-expressing’’ cells with gating based on the intensity of the anti-FLAG signal. The percentageo f
cells infected within each population was quantified. (C) Quantitation of (B). All data presented are means (n=3 6 SD).
doi:10.1371/journal.ppat.1002232.g006
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ESCRT proteins and Alix in infection with an a-DG-independent
LCMV variant. The mutation S153F that distinguished LCMV
WE54 from WE22 lies within GP1, whereas membrane fusion of
arenaviruses is mediated by the transmembrane GP2 moiety.
However, we could at this point not exclude that the S153F
mutation had an impact on the fusion pH of WE22, perhaps
allowing the virus to exit at an earlier stage of the endosomal
pathway. To assess the relative fusion pH of WE 54 and WE22,
the viruses were exposed to progressively more acidic pH for
15 minutes. After neutralization, viruses were added to fresh
monolayers of A549 cells and residual infections titers determined
by immunofocus assay as described [68]. As controls, we used
LCMV cl-13 and rLCMV-LASVGP. In line with published results
[69], we observed a high resistance of rLCMV-LASVGP and
LCMV cl-13 towards acidic pH, with significant inactivation of
the virus only at pH,5.0 (Fig. 9A). LCMV WE54 and WE22
showed similar stability under low pH, indicating that the S153F
mutation in GP1 did not significantly affect the fusion pH (Fig. 9A).
Next, we tested the role of the ESCRT proteins Hrs, Tsg101,
Vps22, Vps24, and the ESCRT-associated protein Alix in cell
entry of LCMV WE22. A549 cells were subjected to RNAi
silencing as described above, followed by infection with LCMV
WE54, LCMV WE22, and rLCMV-LASVGP, which was used as
a positive control. Similar to the results obtained with LCMV cl-
13, infection of both LCMV WE54 and WE22 was significantly
reduced in cells depleted of Hrs, Tsg101, Vps22, Vps24, and Alix
(Fig. 9B), suggesting that a-DG dependent and a-DG independent
LCMV isolates pass through the MVB and require the ESCRT
machinery for cell entry.
The role of the MVB/ESCRT for LASV and LCMV cell entry
is conserved in human cells of the monocyte/
macrophage lineage
Human cells of the monocyte/macrophage lineage are early
and preferred targets of LASV in human and infection of
monocytes and macrophages plays an important role in the
pathogenesis of fatal Lassa fever [1,2]. Considering their
importance as targets in vivo, we investigated LASV cell entry into
human cells of the monocyte/macrophage lineage and in
particular the role of the MVB and ESCRT. For this purpose,
we employed the human monocyte cell line THP-1, which once
differentiated, represents a well-characterized model for human
macrophages. When treated with phorbol 12-myristate 13-acetate
(PMA) for 48 hours, the monocyte THP-1 cells undergo
differentiation and adopt a macrophage-like phenotype with
characteristic morphological changes [70] (Fig. 10A). In a first
step, we optimized siRNA transfection conditions using the
reagent HiPerFect and fluorescence-labeled siRNA and achieved
transfection efficiencies of .90%. We then silenced Hrs, Tsg101,
Vps22, Vps24, and Alix and assessed the efficiency of depletion
after 48 hours by Western-blot and RT-qPCR. For all five targets,
we obtained a degree of depletion similar to the one observed in
A549 cells (Fig. 10B), making this cellular model suitable for our
studies. To assess the role of PI3K and microtubules in LASV and
LCMV cell entry into THP-1 derived macrophage-like cells, cells
were treated with wortmannin and nocodazole, respectively, as
described above. Cells were then infected with VSV pseudotypes
of LASV, LCMV, and VSV via either fusion at the plasma
membrane or normal cell entry. Similar to our results obtained in
Figure 7. Incoming LCMV transiently co-localized with Tsg101 prior to reaching late endosomes. (A) Co-localization of LCMV WE54 with
Tsg101 and Rab7. A549 cells were cooled on ice for 30 min and LCMV WE54 added at an MOI of ,100. After incubation for 1 hour on ice, unbound
virus was washed off, cells shifted to 37uC and fixed at the indicated time points. Cells were then immunostained to detect endogenous Tsg101 or
Rab7 and incoming viral particles. Representative images are shown. Left: LCMV (green) and Tsg101 (red) at 20 min after temperature shift; right:
LCMV (green) and Rab7 (red) at 60 min after temperature shift. Scale bar=5 mm. (B) Quantification of co-localization. Ten randomly selected cells per
time point were analyzed by confocal microscopy and the percentage of co-localizing viruses determined as described in Materials and Methods.
Data presented are means 6 SD (n=10).
doi:10.1371/journal.ppat.1002232.g007
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macrophage-like cells was dependent on PI3K and microtubules
(Fig. 10D). Next we studied the role of LBPA by feeding
macrophage-like cells anti-LBPA antibody, prior to infection with
VSV pseudotypes of LASV, LCMV, and VSV as well as AdV5-
EGFP used as a negative control. As shown in Fig. 10E, pre-
treatment with anti-LBPA, but not control IgG1 significantly
reduced infection with pseudotypes of LASV, LCMV, and VSV,
indicating a role of LBPA in LASV and LCMV entry into
macrophage-like cells.
Lastly, we addressed the role of Hrs, Tsg101, Vps22, Vps24,
and Alix in cell entry of LASV and LCMV into macrophage-like
cells. Briefly, THP-1 cells were differentiated into macrophages
and transfected with siRNAs to Hrs, Tsg101, Vps22, Vps24, and
Alix. After 48 hours, cells were infected with VSV pseudotypes of
LASV, LCMV, and VSV, rLCMV-LASVGP, LCMV, and
AdV5-EGFP. Detection of infection after 16 hours revealed that
depletion of Hrs had no effect on entry of any of the viruses,
whereas silencing of Tsg101, Vps24, and Alix markedly reduced
infection (Fig. 10F). Depletion of Vps22 affected infection with all
viruses, but AdV5-EGFP to a lesser extent. Together, the data
indicate an at least partially conserved cell entry pathway of LASV
pseudotypes and LCMV between A549 cells and macrophage-like
cells with roles for PI3K, microtubules, LBPA, the ESCT proteins
Tsg101, Vps22, Vps24, and Alix, but distinct roles for the
ESCRT-0 component Hrs.
Discussion
In the present study we sought to identify cellular factors
involved in the unusual pathway of cell entry used by Old World
arenaviruses. We found that cell entry of LASV and LCMV
required functional microtubules and PI3K activity. Productive
viral infection depended on LPBA, a lipid involved in the
formation of ILV of the MVB/late endosome, and components
of the ESCRT complex. Productive infection with rLCMV-
LASVGP and LCMV also critically depended on the ESCRT-
associated protein Alix implicated in the membrane dynamics of
late endosomes. In sum our study identifies crucial cellular
components implicated in Old World arenavirus cell entry and
indicates that these viruses invade the host cell passing through the
MVB/late endosome using a pathway that may be involved in
degradation of their cellular receptor.
Previous studies demonstrated a role for microtubules in early
Old World arenavirus infection, but did not distinguish between a
role in viral entry and a requirement for post-entry steps of
replication [21]. In the present study we profited from the fact that
VSV replication in the cytoplasm occurs independent of
microtubules [23] and that recombinant VSV can be efficiently
pseudotyped with the GPs of LCMV and LASV [71]. Using
recombinant VSV pseudotypes, we found that cell entry of LASV
and LCMV critically depended on microtubules prior to fusion,
compatible with a role for microtubular transport in vesicular
trafficking of the virus to the late endosome.
Figure 8. Alix is required for cell entry of LASV and LCMV. (A) A549 cells were transfected with siRNAs specific for Alix or control siRNA and
efficiency of depletion assessed after 72 hours by Western-blot. For normalization, a-tubulin (a-Tu) was used. (B, C) Depletion of Alix perturbed cell
entry of LASV and LCMV. A549 cells were treated with specific siRNAs to Alix and control siRNA as in (A), followed by infection with (B) rVSVDG-
LASVGP (LASV), rVSVDG-LCMVGP (LCMV), rVSVDG-VSVG (VSV), and AdV5-EGFP (AdV) at 500 PFU/well or (C) rLCMV-LASVGP, LCMV, rVSVDG-VSVG
(VSV), and AdV5-EGFP (AdV) (500 PFU/well). Cells were fixed after 16 hours and infection detected by IFA as in Fig. 4 (mean 6 SD; n=3). (D)
Representative specimens of rLCMV-LASVGP infected cells in cultures treated with the indicated siRNAs in (C). LCMV NP is in green and cell nuclei in
blue (bar=20 mM). (E) Depletion of Alix does not interfere with transferrin uptake. Cells treated as in (A) were subjected to transferrin uptake assay as
in Fig. 3D. The cellular distribution of transferrin (red) and cell nuclei stained with DAPI in blue are shown (bar=10 mM). (F) Depletion of Alix does not
affect cell surface expression of a-DG. Cells were subjected to RNAi as in (A) and cell surface staining for a-DG performed after 72 hours as in Fig. 4H.
In histograms, y-axis represents cell numbers and x-axis Alexa 594 fluorescence intensity. Shaded area: primary and secondary antibody, empty area:
secondary antibody only. The broken line indicates the superimposition of the shaded peak (primary+secondary antibody) from cells treated with
control siRNA.
doi:10.1371/journal.ppat.1002232.g008
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independent of known regulatory proteins associated with
endocytosis such as clathrin, caveolin, dynamin, flotillin, or
ARF6 and appears to bypass Rab5- and EEA1 positive early
endosomes [19,20,21]. Infection of cells by LASV and LCMV
critically depends on a-DG that functions as a high affinity
receptor for Old World arenaviruses [14,67,72]. Considering the
negligible off-rate of the virus-receptor binding [71,73], it is
conceivable that the virus-receptor complex is internalized and
follows a pathway normally associated with endocytosis and
degradation of a-DG. To test this hypothesis, we addressed the
role of the MVB/late endosome in viral entry.
The formation of a functional MVB requires the biosynthesis of
the membrane lipid PI3P by PI3K [41]. Since the post-fusion steps
of VSV replication do not depend on PI3K activity [23], we again
employed recombinant VSV pseudotypes to address a possible
role for PI3K in cell entry of LASV and LCMV. In contrast to
VSV that can undergo fusion at the level of the early endosome
and is not inhibited by the PI3K inhibitor wortmannin [23],
infection with the LASV and LCMV pseudotypes was markedly
reduced. The dependence on PI3K at the level of viral entry
provided a first hint towards a requirement for a functional MVB.
To address the role of the MVB in LASV and LCMV cell entry
more specifically, we perturbed the function of LBPA, an unusual
lipid that is crucial for the formation of the MVB [42]. For this
purpose we pre-treated cells with the well-characterized function-
blocking antibody 6C4 to LBPA, which selectively prevents the
formation of ILV in the MVB/late endosome [42]. Anti-LBPA
treatment significantly perturbed LASV and LCMV cell entry,
suggesting a role of the MVB. To address the role of the ESCRT
complex, we depleted selected components of ESCRT-0 through
III, namely Hrs, Tsg101, Vps22, and Vps24, respectively, using
firmly established RNAi protocols. Depletion of Hrs, Tsg101,
Vps22, and Vps24 under our experimental conditions markedly
reduced cell entry of LASV and LCMV, but only mildly affected
infection with AdV5 and did not affect early endosomal trafficking
of TfR1, excluding general perturbation of membrane trafficking
and/or endocytosis. Similar results were obtained upon over-
expression of a DN variant of the ESCRT-associated ATPase
Vps4 that is essential for the terminal fission of ILV. While
depletion of Tsg101 markedly reduced viral infection, over-
expression of recombinant Tsg101 significantly accelerated cell
entry of LASV and LCMV, further supporting a role for Tsg101
as a positive regulator of Old World arenavirus entry. A role of the
MVB for viral entry is also supported by the reduced susceptibility
of cells depleted for Alix, an ESCRT-associated protein that is
involved in the organization of the MVB in an LBPA-dependent
manner [42]. To corroborate our findings obtained with RNAi
and recombinant proteins that pinpoint a role for the ESCRT in
Old World arenavirus entry, we performed co-localization studies
between the prototypic LCMV and Tsg101 using confocal
microscopy. Our studies indicate that incoming virus transiently
passes through a compartment associated with Tsg101, and is
subsequently delivered to Rab7 positive late endosomes, consistent
with a passage through the MVB and sorting by the ESCRT.
Figure 9. Infection of the a-DG independent LCMV WE22 also depends on ESCRT proteins. (A, B) Depletion of Hrs, Tsg101, Vps22, Vps24,
and Alix. A549 cells were subjected to siRNA knock down of Hrs, Tsg101, Vps22, Vps24, and Alix as in Figs. 4A and 8A. Depletion of Hrs, Tsg101, and
Alix was verified by Western blot as in 4A and 8A. The know-down of Vps22 and Vps24 was validated by detection of mRNA using RT-qPCR as in 4B.
(C) LCMV WE22 retains the low fusion pH of WE54. LCMV WE54, WE22, cl-13 and rLCMV-LASVGP (10
7 PFU/ml) were exposed to buffer solution with
the indicated pH for 15 minutes. Samples were immediately neutralized and infectious virus titers determined by immunofocus assay on fresh
monolayers of A549 cells. Means of 2 independent experiments are shown. (D) Infection with LCMV WE22 depends on Hrs, Tsg101, Vps22, Vps24, and
Alix. A549 cells were subjected to RNAi silencing of Hrs, Tsg101, Vps22, Vps24, and Alix as in (A) and (B) respectively. After 72 hours cells were infected
with the indicated viruses (500 PFU/well) and infection assessed after 16 hours by IFA (mean 6 SD; n=3).
doi:10.1371/journal.ppat.1002232.g009
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[19] and LCMV cl-13 [20] bind to a-DG with high affinity and
are dependent on a-DG for cell entry [67]. However, a single
point mutation in the GP1 of WE54, S153F, present in the isolate
WE22 [74], abolishes a-DG binding and makes WE22 indepen-
dent of a-DG [67]. Comparison of the stability of WE54 and
WE22 towards acidic pH revealed that WE22 retained the
unusually high acid stability and low fusion pH found in LCMV
Figure 10. Cell entry of LASV and LCMV into human macrophages depends on the MVB and ESCRT proteins. (A) Differentiation of THP-
1 cells into macrophages. THP-1 cells were treated with 50 ng/ml PMA for 48 hours and changes in cell morphology assessed by differential
interference contrast microscopy (bar=20 mM). (B) THP1 cells were seeded in 96 well plates (2610
4 cells/well) and differentiated into macrophage-
like cells as in (A). Cells were then transfected with siRNAs for Hrs, Tsg101, Alix, or control siRNA and efficiency of depletion assessed after 48 hoursb y
Western-blot as in Fig. 4A. For normalization, a-tubulin (a-Tu) was used. (C) Cells were transfected with siRNAs for Vps22 and Vps24 or control siRNA
and efficiency of depletion assessed after 48 hours by quantification of mRNA levels by RT-qPCR as in Fig. 4B. (D) Cell entry of LASV and LCMV into
human macrophage-like cells depends on PI3K and microtubules. THP1-derived macrophage-like cells generated as in (A) were treated with the
indicated concentrations of wortmannin and nocodazole. Cells were then infected with rVSVDG-LASVGP (LASV), rVSVDG-LCMVGP (LCMV), and
rVSVDG-VSVG (VSV) either via fusion at the plasma membrane (2000 PFU/well) or via the normal route of infection (200 PFU/well) as in Fig. 2.
Infection was detected by scoring EGFP positive cells (mean 6 SD; n=3). (E) Infection of VSV pseudotypes of LASV, LCMV, and VSV is perturbed by
anti-LBPA treatment. THP-1-derived macrophage-like cells were pre-incubated with no antibody (1), 50 mg/ml mAb anti-LBPA (2) or isotype antibody
control (3) for 14 hours. Cells were then infected with rVSVDG-LASVGP (LASV), rVSVDG-LCMVGP (LCMV), rVSVDG-VSVG (VSV), and AdV5-EGFP at 300
PFU/well. In specimens subjected to pretreatment only (4), the cells were incubated for 1 h at 4uC with viruses in presence of the antibody, unbound
virus washed out, and cell incubated at 37uC in normal medium. Cells were fixed after 16 hours and EGFP positive cells counted (mean 6 SD; n=3).
(F) Cell entry of LASV and LCMV into human macrophages depends on Tsg101, Vps22, Vps24, and Alix, but not Hrs. THP-1-derived macrophage-like
cells were subjected to RNAi silencing of Hrs, Tsg101, Vps22, Vps24, and Alix as in (B) and (C). After 48 hours cells were infected with rVSVDG-LASVGP
(VSV-LASV), rVSVDG-LCMVGP (VSV-LCMV), rVSVDG-VSVG (VSV-VSV), rLCMV-LASVGP, LCMV, and AdV5-EGFP (AdV) at 300 PFU/well. Infection was
assessed after 16 hours by IFA (mean 6 SD; n=3).
doi:10.1371/journal.ppat.1002232.g010
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proteins Hrs, Tsg101, Vps22, and Vps24, as well as Alix, infection
of the a-DG-independent LCMV WE22 was affected to a similar
extent as the a-DG-dependent viruses LCMV WE54, LCMV cl-
13, and rLCMV-LASVGP. Although by no means comprehen-
sive, these studies with WE22 indicate that also an a-DG-
independent LCMV isolate passes through the MVB and depends
on ESCRT-mediated sorting for productive infection, which may
be linked to the use of a yet unknown cellular membrane receptor
and/or the unusually low fusion pH of the virus.
To study LASV and LCMV cell entry we largely used the
human epithelial cell line A549. While a good model for epithelial
cells that are important targets of arenaviruses in vivo, they are
different from human cells of the monocyte/macrophage lineage,
which represent key targets for LASV involved in the pathogenesis
of fatal Lassa fever [2]. Using a well-characterized cell culture
model for human macrophages, we assessed the roles of the MVB
and ESCRT in LASV and LCMV cell entry. These studies
revealed that LASV and LCMV cell entry into macrophage-like
cells also depends on a functional MVB and the ESCRT
components Tsg101, Vps22, and Vps24, as well as Alix. However,
in contrast to A549 and HEK293 cells, infection of macrophage-
like cells seemed independent of Hrs. Since Hrs is a constituent of
ESCRT-0 that recruits cargo to the ESCRT-I, our data suggest
that the initial events of LASV cell entry, prior to the interaction
with ESCRT-I, are distinct in A549 cells and macrophages-like
cells. This difference may be linked to differential receptor use
and/or another endocytotic pathway involved in virus internali-
zation. As befits their role in pathogen detection and antigen
presentation, macrophages express a number of pathogen
recognition receptors (PRR) and have pathways of endocytosis
that do not exist in other cell types [75,76]. Their role in LASV
infection of human macrophages is currently unknown and under
investigation in our laboratory.
The requirement for the MVB/late endosome for cell entry of
LASV and LCMV found here is reminiscent to earlier reports on
the cellular entry of the Anthrax toxin, the major virulence factor
of Bacillus anthracis [60,77], as well as studies on the endosomal
transport of influenza virus [78] and VSV [23]. In case of Anthrax
toxin and VSV, the pathogens undergo ESCRT-mediated sorting
into ILV for transport to the late endosome, where penetration
into the cytosol occurs by back-fusion of ILV with the endosomal
membrane [23,60]. Due to its pH optimum for fusion of .6.0,
VSV penetrates the ILV membrane at an early step, resulting in
the accumulation of the viral nucleocapsids in the lumen of ILV
[23]. Delivery of VSV nucleocapsids into the cytoplasm at the level
of the late endosome most likely occurs by back-fusion and
involves LBPA, Alix, and Tsg101 [23,79]. To ‘‘hide’’ the viral
nucleocapsid in the lumen of ILV during the passage through the
MVB/late endosome may be a strategy to protect the virus against
the increasingly hostile biochemical environment of the late
endosome. In contrast to VSV, LASV and LCMV have a
remarkably low pH optimum for fusion (,5.0) [18,69] and in
particular LASV is unusually resistant to acidic pH [69]. It seems
therefore rather unlikely that fusion can occur before the viruses
reach late endosomal/lysosomal compartments.
Based on previous studies and the present work, we propose a
working model for the cell entry of Old World arenaviruses
(Fig. 11). LASV, most LCMV isolates, and the related African
arenaviruses Mobala and Mopeia use a-DG as a high affinity
cellular receptor (1). Virus-receptor binding may result in receptor
clustering, possibly accompanied by receptor-mediated signaling.
Upon attachment, virus is rapidly internalized by smooth vesicles
(2) [17,19] involving a clathrin- and caveolin-independent
pathway [19,20,21]. Based on the negligible off-rate of the virus
binding to a-DG at neutral pH [71,73], we assume that the virus-
receptor complex is internalized. In a Rab5-independent manner,
virus-containing vesicles may then be delivered either directly to
the MVB (3) or passing through a yet unknown intracellular
compartment (?), which seems distinct from classical EEA1
positive early endosomes. The MVB is a dynamic organelle
characterized by the presence of ILV that gives raise to late
endosomes. Delivery of the virus-receptor complex within the
MVB to late endosomes seems to depend on microtubular
transport (4), but independent of Rab7 [19,21]. At the level of
the MVB, the virus-receptor complex may undergo ESCRT-
mediated sorting into ILV (5), followed by delivery to the late
endosome. To allow penetration of the viral nucleocapsid into the
cytosol, ILV bearing virus-receptor complexes would have to
undergo back-fusion at the level of the late endosome, which may
depend on Alix and LBPA (6). However, we cannot exclude the
possibility that the virus-receptor complex may to some extent
remain associated with the limiting membrane of the MVB (7) and
fusion may be initiated as the intraluminal pH progressively drops
(8).
A hallmark of fatal LASV infection in humans is the inability of
the host cell’s innate immune system to detect and contain the
virus, resulting in uncontrolled infection [2]. Instead of being
recognized as a foreign antigen, LASV escapes innate pathogen
detection and establish a productive infection without inducing an
interferon response [80,81]. An important class of cellular PRRs
that allows early detection of incoming RNA viruses are
transmembrane receptors of the Toll-like family localized in the
Rab5/EEA1 positive early endosome [82]. The ability of LASV to
use a pathway of endocytosis bypassing classical routes of
incoming endosomal trafficking followed direct delivery to late
endosomes may contribute to LASV’s ability to escape detection
by endosomal receptors of innate anti-viral defense, a hypothesis
we are currently testing.
Materials and Methods
Antibodies and reagents
Mouse monoclonal antibody (mAb) 113 anti-LCMV NP has
been described previously [83]. Mouse mAbs recognizing Hrs
and Tsg101 were purchased from Alexis Biochemicals (Lausen,
Switzerland) and GeneTex (Irvine, CA), while rabbit polyclonal
antibody (pAb) anti-Alix was from Covalab (Villeurbanne,
France). MAb IIH6 anti-a-DG has been provided by Dr. Kevin
Campbell (Howard Hughes Medical Institute, University of
Iowa). MAb to clathrin heavy chain was purchased from BD
Bioscience (San Jose, CA). Mouse mAb anti-FLAG M2, rabbit
pAb anti-FLAG and mouse mAb anti-a-tubulin were all obtained
from Sigma-Aldrich (St. Louis, MO). Mouse mAb 6C4 anti-
LBPA [84] was a kind gift of Dr. Jean Gruenberg (University of
Geneva, Switzerland). Mouse mAb 23H12 specific for the M
protein of VSV [85] was kindly provided by Dr. Douglas S. Lyles
(Wake Forest University School of Medicine, NC). Mouse mAb
anti-MYC was produced from the 9E10 hybridoma. Horseradish
peroxidase (HRP) conjugated secondary antibodies were from
Pierce (Rockford, IL), rhodamine red-X goat anti-mouse IgG
from Jackson ImmunoResearch (Suffolk, UK), while Alexa 594
goat anti-mouse IgM, Alexa 488 goat anti-mouse IgG2a, Alexa
647 goat anti-rabbit IgG and 49,6-diamidino-2-phenylindole
(DAPI) were purchased from Molecular Probes (Eugene, OR)
and phorbol 12-myristate 13-acetate (PMA) was obtained from
Sigma.
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Human lung adenocarcinoma epithelial cells (A549), human
embryonic kidney cells (HEK293), African green monkey kidney
cells (Vero E6), North African green monkey (Cercopithecus aethiops)
kidney fibroblasts (CV1), and Syrian golden hamster kidney cells
(BHK-21) were maintained in Dulbecco’s modified Eagle medium
(DMEM) (Gibco BRL, NY) containing 10% FBS. THP-1 cells
were maintained and differentiated into macrophages as described
[70]. LCMV clone 13 (cl-13) and recombinant LCMV carrying
the LASV GP (rLCMV-LASVGP) have been already described
[21,86]. Seed stocks of LCMV were prepared by growth in BHK-
21 cells, and titers were determined as reported previously [87].
Wild-type vesicular stomatitis virus (VSV) (Indiana serotype) was
grown in Vero E6 cells, and titers were determined by plaque
assay on Vero E6 cells. Recombinant VSV pseudotyped with
LASV GP (rVSVDG-LASVGP), LCMV GP (rVSVDG-
LCMVGP), and VSV GP (rVSVDG -VSVG) were generated as
reported previously [71]. Virus titers were determined by the
infection of Vero E6 cell monolayers and detection of GFP-
positive cells by fluorescence microscopy.
Virus infection and fusion assay
For virus infection, 2610
4 cells per well were seeded in 96 well
plates and cultured overnight. For infection of cells with LCMV,
rLCMV-LASVGP and VSV, seed stocks were diluted to the
indicated MOI and added to cells for 1 h at 37uC. After 1 h of
incubation, the inoculum was removed, and replaced with normal
medium. To prevent secondary infection, 20 mM NH4Cl was
added to the cells 4 h after infection. Cells were fixed 5 (VSV) or
16 (LCMV cl-13 and rLCMV-LASVGP) h after infection and
infected cells quantified by immunofluorescence assay (IFA)
detection of LCMVNP and VSVM using mAbs 113 (anti-
LCMVNP) and 23H12 (anti-VSVM) combined with fluores-
cence-labeled secondary antibodies as in [88]. Images of infected
cells within one experiment were acquired with the same
microscope settings using a Zeiss LSM 510 Meta confocal
microscope (Zeiss) and a 406, 1.3 NA or a 206objective.
For infection of cells with rVSVDG-LCMVGP, rVSVDG-
LASVGP and rVSVDG-VSVGP, seed stocks were diluted to the
indicated MOI and added to cells for 1 h at 37uC. After 1 h of
incubation, the inoculum was removed, and replaced with normal
medium. Cells were fixed at 12 h after infection and GFP-positive
cells, or cells stained with mAb 23H12 to VSV-M, scored as
infected by flow cytometry or fluorescence microscopy.
The kinetics of cell entry by ammonium chloride treatment was
performed as described [21]. Briefly, cells were cooled on ice for
30 min and viruses added the indicated MOI. After incubation for
1 h on ice, unbound virus was washed off and cells were quickly
shifted to 37uC. After the indicated time points, 20 mM
ammonium chloride was added to the medium and kept
throughout the experiment. After a total of 12 (rVSVDG-
LASVGP and rVSVDG-VSVGP) or 16 (rLCMV-LASVGP) h,
cells were fixed, stained and analyzed by flow cytometry.
Pharmacological inhibitors
For cholesterol extraction with methyl-b-cyclodextrin (MbCD),
medium was removed, cells washed twice with medium without
FBS, and MbCD added at the indicated concentrations for one
Figure 11. Working model for the cell entry of the Old World arenaviruses LASV and LCMV. For details please see text.
doi:10.1371/journal.ppat.1002232.g011
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medium to remove residual MbCD and infection assays
performed as described. For the quantitative determination of
cellular cholesterol, cells were extracted with chloroform and
methanol (2:1) and cholesterol quantified by a commercial
colorimetric assay (BioVision Inc. Mountain View, CA) according
to the manufacturer’s recommendations. Treatment with chlor-
promazine (CPZ) was performed as described [28]. Studies with
nocodazole to address the role of microtubules and wortmannin to
define the role PI3K for cell entry of VSV pseudotypes were
performed as described [23]. All pharmacological inhibitors were
purchased from Sigma-Aldrich (St. Louis, MO).
Infection assays with wild-type and dominant negative
mutants of dynamin, Eps15, and Rab5
Green fluorescent protein (GFP)-tagged wild-type and DN
(K44E) dynamin II [38] were kindly provided by Dr. Sandra L.
Schmid (The Scripps Research Institute, CA) and the control Eps
15DIIID2 construct [34] as well as the DN Eps15D95/295 mutant
construct [89] were provided by Drs Alice Daurty-Varsat and
Nathalie Sauvonnet (Institut Pasteur, Paris). Constructs of wild-
type GFP-tagged human Rab5A and the constitutively inactive
mutant Rab5 S34N [90,91] were provided by Dr. Craig Roy (Yale
University School of Medicine, New Haven, CT). The impact of
transgene expression on virus infection was assessed as described
[20]. Briefly, cells were transiently transfected with plasmid DNA
using the Nucleofector system (Amaxa, Gaithersburg, MD)
according to the manufacturer’s protocols. Transfection efficien-
cies with plasmids, as assessed by detection of GFP, were .90%
for HEK293 cells. Cells expressing GFP-tagged constructs for
20 hours were infected with VSV pseudotypes rVSVDG-
LASVGP, rVSVDG-LCMVGP and rVSVDG-VSVG at 200
PFU/well. Infection of VSV pseudotypes was detected by IFA
using mAb 23H12 specific for the M protein of VSV and a
rhodamine red X-conjugates secondary antibody. The number of
VSV M positive cells was determined for each well in triplicates.
RNA interference (RNAi)
The depletion of clathrin heavy chain by RNAi was performed
as described in [92] using ON-TARGETplus SMARTpool and a
control siRNA pool obtained from Dharmacon (Lafayette, CO).
Briefly, cells (2610
4 cell/well) were seeded in 96 well plates and
transfected with siRNAs at concentrations of 50 nM per siRNA,
corresponding to a total concentration of 4650=200 nM, using
Lipofectamine 2000. After 48 hours, cells were lysed and depletion
of clathrin heavy chain and caveolin-1 detected by Western-blot
analysis, using a-tubulin for normalization.
For the knockdown of ESCRT components, validated siRNAs
for human Hrs (SI00288239), Alix (SI02655345) and scrambled
siRNA (1027280) were purchased from Qiagen (Basel, Switzer-
land) while target sequences for human Tsg101, Vps22 and Vps24
were previously described in [93], [50], and [49] respectively. In
RNAi experiments, A549, HEK293, and CV-1 cells were
transfected twice at a 24 h interval with 16 nM siRNA using
Lipofectamine RNAiMAX (Invitrogen, Paisley, UK) according to
the manufacturer’s instructions, replated the day after the second
transfection and further manipulated 24 h later. THP-1 cells were
differentiated by the addition of PMA (50 ng/ml) for 48 hours and
then transfected with HiPerFect (Qiagen) according to the
manufacturers recommendation, using 50 nM of siRNA.
Anti-LBPA antibody treatment
BHK-21 cells were left untreated, pre-incubated with 50 mg/ml
of anti-LBPA antibody or with 50 mg/ml of isotype IgG control for
14 h and infected with LCMV, rLCMV-LASVGP and VSV. To
exclude a direct effect of the anti-LBPA Ab on virus infectivity,
untreated cells were incubated for 1 h at 4uC with LCMV,
rLCMV-LASVGP and VSV in presence of the Ab, unbound virus
washed out, and cell incubated at 37uC in normal medium.
Immunoblotting
Standard immunoblotting involved proteins being separated by
SDS-PAGE gel electrophoresis and transferred to nitrocellulose.
After blocking in 3% (wt/vol) skim milk in PBS, membranes were
incubated with 1–10 mg/ml primary antibody in 3% (wt/vol) skim
milk, PBS overnight at 4uC. After several washes in PBS, 0.1%
(wt/vol) Tween-20 (PBST), secondary antibodies coupled to HRP
were applied 1:5,000 in PBST for 1 h at room temperature. Blots
were developed by enhanced chemiluminescence (ECL) using
Super Signal West Pico ECL Substrate (Pierce).
Real time PCR
Total RNA was purified with RNeasy Mini Kit (Qiagen) and
cDNA synthesized using QuantiTect Reverse Transcription Kit
(Qiagen). TaqMan probes specific for Vps22 (Hs00273125_m1),
Vps24 (Hs00984915_m1) and PRKCSH (Hs00160457_m1) were
obtained from Applied Biosystems. Real Time PCR was
performed using StepOne Real-Time PCR System (Applied
Biosystems) and gene expression levels relative to PRKCSH
determined according to the 2
2DDCT method [94].
Transferrin uptake assay
Transferrin uptake assay was performed according to [95]. Cells
were incubated for 10 min at 37uC with serum-free medium
containing 20 mg/ml of Alexa594-labeled human transferrin
(Invitrogen), washed with ice cold PBS and acid-stripped
(150 mM NaCl, 2 mM CaCl2,2 5m MC H 3COONa, pH 4.5) to
remove surface-bound transferrin. Cells were immediately fixed
with 2% formaldehyde in PBS for 15 min and specimens
examined with the same microscope settings using a Zeiss LSM
510 Meta confocal microscope (Zeiss) and a 406, 1.3 NA
objective.
Infection assays with wild-type and dominant negative
mutants of Vps4A
Expression plasmids for human FLAG-tagged Vps4A and
Vps4A mutant E228Q (Vps4AEQ) [56] were kindly provided by J.
Yasuda (Japan Science and Technology Agency, Japan). HEK293
cells were transfected using FuGENE6 and 36 h after cells infected
with LCMV or rLCMV-LASVGP (MOI,1). 20 mM ammonium
chloride was added 4 hours post infection to prevent secondary
infection. Sixteen h post infection, cells were fixed and
immunostaining against LVMV-NP and FLAG tag performed.
Two populations of cells were selected in each sample: a ‘‘non-
expressing’’ population negative for flag and an ‘‘expressing’’
population containing the construct. The percentage of cells
infected within each population was quantified in a histogram of
the virus staining intensity. The effect of a given flag-fusion protein
was expressed as normalized infection level, i.e., the ratio of the
infection level in the cell population expressing the protein divided
by the infection level in the non-expressing cell population.
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pC-Tsg101 [96] carrying a MYC tag upstream the human
coding sequence was from S. N. Cohen (Stanford University
School of Medicine, CA). In transfection experiments, HEK293
cells were transfected using FuGENE6 (Roche, Basel, Switzerland)
according to the manufacturer’s protocol, and infected 36 h after.
Cell surface staining of a-DG
For cell surface staining, cells were detached with enzyme-free
cell dissociation solution (Sigma-Aldrich), resuspended in FACS
buffer (1% (vol/vol) FBS, 0.1% (wt/vol) sodium azide, PBS), and
plated in conical 96-well trays. For cell surface staining of
functionally glycosylated a-DG, cells were incubated with mAb
IIH6 (1:100). Incubation was for one hour on ice in FACS buffer.
Cells were then washed twice in FACS buffer and labeled with
Alexa 594-conjugated secondary antibodies (1:100 in FACS
buffer) for 45 min on ice in the dark. After two wash-steps in
1% (vol/vol) FBS in PBS, cells were fixed with 4% (wt/vol)
paraformaldehyde, PBS for 10 min at room temperature in the
dark. The cells were washed twice with PBS, and analyzed with a
FACSCalibur flow cytometer (Becton Dickinson, San Jose CA)
using Cell Quest software.
Virus inactivation assay
To compare the fusion pH of different LCMV isolates, viruses
were incubated with 100 mM sodium citrate solutions buffered at
the indicated pH for 15 min. Titers after incubation were
determined by infection of A549 monolayer as described
previously [68].
Co-localization analysis
To perform co-localization studies A549 cells previously seeded
on glass 8-well LabTeks were cooled on ice for 30 min, incubated
for 1 h on ice with LCMV WE54 (MOI,100) to allow virus
binding and then washed with cold medium. Cells were then
shifted at 37uC and fixed at the indicated time points with 2%
formaldehyde in PBS for 15 minutes at RT and washed with PBS.
Cells were permeabilized for 30 min at RT with 0.1% saponin,
10% goat serum, 100 mM glycine in PBS. Primary (mouse
monoclonal anti LCMV NP clone 113 2 mg/ml, rabbit polyclonal
anti Tsg101 1:100, GeneTex, and rabbit polyclonal anti-Rab7
1:100, Cell Signaling) and secondary antibodies (Alexa488-F(ab9)2
fragment of goat anti-mouse IgG and Alexa595-F(ab9)2 fragment
of goat anti-rabbit IgG, Molecular Probes) were diluted in PBS,
0.1% saponin, 1% goat serum and incubated o/n at 4uC and 1 h
at RT, respectively. Before acquisition nuclei were stained with
300 nM DAPI and LabTek were mounted with ProLong Gold
(Molecular Probes). Image acquisition was performed with a Zeiss
LSM710 Quasar confocal microscope equipped with a plan
apochromat 636, 1.2 NA objective and a 405 nm diode laser, a
458-476-488-514 nm Argon laser and a 561 nm DPSS. All images
for each data set were acquired the same day with the same
microscope settings. Images were first deconvolved using Huygens
Essential (SVI, Hilversum, Netherlands) and then analyzed for
colocalization with Imaris 7.2 (Bitplane). For each image a
colocalization channel was built thresholding the scatter plot.
Total number of viruses and the number of viruses in the
colocalization channel were automatically quantified by image
segmentation using Imaris spot detection function to model point-
like structures. Ten randomly selected cells for each time points
were analyzed.
Acknowledgments
We thank Dr. Amalio Telenti (University of Lausanne) and Dr. Michael B.
A. Oldstone (Scripps Research Institute, La Jolla) for their generous
support. The authors further thank Dr. Gisou van der Goot (Ecole
Polytechnique Fe ´de ´rale Lausanne) and Dr. Jean Gruenberg (University of
Geneva) for reagents and valuable discussions. We acknowledge Dr.
Sandra L. Schmid (Scripps Research Institute) for the expression plasmids
for wild type and the DN mutants of dynamin, Drs. Alice Dautry-Varsat
and Nathalie Sauvonnet (Institut Pasteur, Paris) for expression vectors for
control and DN mutant Eps15, and Dr. Craig Roy (Yale University School
of Medicine, New Haven, CT) for the DN and wild-type Rab5 constructs.
Expression plasmids for human FLAG-tagged Vps4A and Vps4A mutant
E228Q (Vps4AEQ) were kindly provided by J. Yasuda and MYC-tagged
Tsg101 by S. N. Cohen (Stanford University School of Medicine, CA). We
are grateful to Arnaud Paradis and Yannick Krempp (Cellular Imaging
Facility, University of Lausanne) for technical help for co-localization
experiments.
Author Contributions
Conceived and designed the experiments: GP JMR JYC SK. Performed
the experiments: GP JMR MM SK. Analyzed the data: GP JMR JYC SK.
Contributed reagents/materials/analysis tools: JYC. Wrote the paper: GP
SK.
References
1. Geisbert TW, Jahrling PB (2004) Exotic emerging viral diseases: progress and
challenges. Nat Med 10: S110–121.
2. McCormick JB, Fisher-Hoch SP (2002) Lassa fever. Curr Top Microbiol
Immunol 262: 75–109.
3. Richmond JK, Baglole DJ (2003) Lassa fever: epidemiology, clinical features,
and social consequences. BMJ 327: 1271–1275.
4. McCormick JB, King IJ, Webb PA, Johnson KM, O’Sullivan R, et al. (1987) A
case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis
155: 445–455.
5. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, et al. (1995)
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor
medical practice. BMJ 311: 857–859.
6. Barton LL, Mets MB, Beauchamp CL (2002) Lymphocytic choriomeningitis
virus: emerging fetal teratogen. Am J Obstet Gynecol 187: 1715–1716.
7. Jahrling PB, Peters CJ (1992) Lymphocytic choriomeningitis virus. A neglected
pathogen of man. Arch Pathol Lab Med 116: 486–488.
8. Mets MB, Barton LL, Khan AS, Ksiazek TG (2000) Lymphocytic choriomen-
ingitis virus: an underdiagnosed cause of congenital chorioretinitis.
Am J Ophthalmol 130: 209–215.
9. Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, et al. (2006)
Transmission of lymphocytic choriomeningitis virus by organ transplantation.
N Engl J Med 354: 2235–2249.
10. Peters CJ (2006) Lymphocytic choriomeningitis virus–an old enemy up to new
tricks. N Engl J Med 354: 2208–2211.
11. Buchmeier MJ, de la Torre JC, Peters CJ (2007) Arenaviridae: the viruses and
their replication. In: Knipe DL, Howley PM, eds. Fields Virology. 4th ed.
Philadelphia: Lippincott-Raven. pp 1791–1828.
12. Marsh M, Helenius A (2006) Virus entry: open sesame. Cell 124: 729–740.
13. Smith AE, Helenius A (2004) How viruses enter animal cells. Science 304:
237–242.
14. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, et al. (1998) Identification
of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and
Lassa fever virus [see comments]. Science 282: 2079–2081.
15. Barresi R, Campbell KP (2006) Dystroglycan: from biosynthesis to pathogenesis
of human disease. J Cell Sci 119: 199–207.
16. Spiropoulou CF, Kunz S, Rollin PE, Campbell KP, Oldstone MB (2002) New
World arenavirus clade C, but not clade A and B viruses, utilizes alpha-
dystroglycan as its major receptor. J Virol 76: 5140–5146.
17. Borrow P, Oldstone MB (1994) Mechanism of lymphocytic choriomeningitis
virus entry into cells. Virology 198: 1–9.
18. Klewitz C, Klenk HD, ter Meulen J (2007) Amino acids from both N-terminal
hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical
for pH-dependent membrane fusion and infectivity. J Gen Virol 88: 2320–2328.
19. Quirin K, Eschli B, Scheu I, Poort L, Kartenbeck J, et al. (2008) Lymphocytic
choriomeningitis virus uses a novel endocytic pathway for infectious entry via
late endosomes. Virology 378: 21–33.
20. Rojek JM, Perez M, Kunz S (2008) Cellular entry of lymphocytic choriomen-
ingitis virus. J Virol 82: 1505–1517.
Old World Arenaviruses Cell Entry
PLoS Pathogens | www.plospathogens.org 17 September 2011 | Volume 7 | Issue 9 | e100223221. Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S (2008) Different
mechanisms of cell entry by human-pathogenic Old World and New World
arenaviruses. J Virol 82: 7677–7687.
22. Vonderheit A, Helenius A (2005) Rab7 associates with early endosomes to
mediate sorting and transport of Semliki forest virus to late endosomes. PLoS
Biol 3: e233.
23. Le Blanc I, Luyet PP, Pons V, Ferguson C, Emans N, et al. (2005) Endosome-to-
cytosol transport of viral nucleocapsids. Nat Cell Biol 7: 653–664.
24. Takada A, Robison C, Goto H, Sanchez A, Murti KG, et al. (1997) A system for
functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94:
14764–14769.
25. Kunz S, Rojek J, Perez M, Spiropoulou C, MB O (2005) Characterization of the
interaction of Lassa fever virus with its cellular receptor a-dystroglycan. J Virol
79: 5979–5987.
26. Lyles DS, Rupprecht CE (2007) Rhabdoviridae. In: Knipe DM, Howley PM,
eds. Fields Virology. 5th ed. Philadelphia: Lippincott. 1363 p.
27. Pinschewer DD, Perez M, Jeetendra E, Bachi T, Horvath E, et al. (2004)
Kinetics of protective antibodies are determined by the viral surface antigen.
J Clin Invest 114: 988–993.
28. Clemente R, de la Torre JC (2009) Cell entry of Borna disease virus follows a
clathrin-mediated endocytosis pathway that requires Rab5 and microtubules.
J Virol 83: 10406–10416.
29. Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A (2009) Host
cell factors and functions involved in vesicular stomatitis virus entry. J Virol 83:
440–453.
30. Ohkuma S, Poole B (1978) Fluorescence probe measurement of the
intralysosomal pH in living cells and the perturbation of pH by various agents.
Proc Natl Acad Sci U S A 75: 3327–3331.
31. Ohkuma S, Poole B (1981) Cytoplasmic vacuolation of mouse peritoneal
macrophages and the uptake into lysosomes of weakly basic substances. J Cell
Biol 90: 656–664.
32. Shah WA, Peng H, Carbonetto S (2006) Role of non-raft cholesterol in
lymphocytic choriomeningitis virus infection via alpha-dystroglycan. J Gen Virol
87: 673–678.
33. Vela EM, Zhang L, Colpitts TM, Davey RA, Aronson JF (2007) Arenavirus
entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated
endocytic mechanism. Virology 13: 13.
34. Benmerah A, Lamaze C, Begue B, Schmid SL, Dautry-Varsat A, et al. (1998)
AP-2/Eps15 interaction is required for receptor-mediated endocytosis. J Cell
Biol 140: 1055–1062.
35. Nichols BJ (2002) A distinct class of endosome mediates clathrin-independent
endocytosis to the Golgi complex. Nat Cell Biol 4: 374–378.
36. Damke H, Baba T, Warnock DE, Schmid SL (1994) Induction of mutant
dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol 127:
915–934.
37. Oh P, McIntosh DP, Schnitzer JE (1998) Dynamin at the neck of caveolae
mediates their budding to form transport vesicles by GTP-driven fission from the
plasma membrane of endothelium. J Cell Biol 141: 101–114.
38. van der Bliek AM, Redelmeier TE, Damke H, Tisdale EJ, Meyerowitz EM,
et al. (1993) Mutations in human dynamin block an intermediate stage in coated
vesicle formation. J Cell Biol 122: 553–563.
39. Gruenberg J (2001) The endocytic pathway: a mosaic of domains. Nat Rev Mol
Cell Biol 2: 721–730.
40. Zerial M, McBride H (2001) Rab proteins as membrane organizers. Nat Rev
Mol Cell Biol 2: 107–117.
41. Raiborg C, Stenmark H (2009) The ESCRT machinery in endosomal sorting of
ubiquitylated membrane proteins. Nature 458: 445–452.
42. Matsuo H, Chevallier J, Mayran N, Le Blanc I, Ferguson C, et al. (2004) Role of
LBPA and Alix in multivesicular liposome formation and endosome organiza-
tion. Science 303: 531–534.
43. Henry MD, Campbell KP (1998) A role for dystroglycan in basement membrane
assembly. Cell 95: 859–870.
44. Hall K, Blair Zajdel ME, Blair GE (2010) Unity and diversity in the human
adenoviruses: exploiting alternative entry pathways for gene therapy. Biochem J
431: 321–336.
45. Meier O, Greber UF (2004) Adenovirus endocytosis. J Gene Med 6 Suppl 1:
S152–163.
46. Bache KG, Brech A, Mehlum A, Stenmark H (2003) Hrs regulates
multivesicular body formation via ESCRT recruitment to endosomes. J Cell
Biol 162: 435–442.
47. Babst M, Odorizzi G, Estepa EJ, Emr SD (2000) Mammalian tumor
susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both
function in late endosomal trafficking. Traffic 1: 248–258.
48. Razi M, Futter CE (2006) Distinct roles for Tsg101 and Hrs in multivesicular
body formation and inward vesiculation. Mol Biol Cell 17: 3469–3483.
49. Bache KG, Stuffers S, Malerod L, Slagsvold T, Raiborg C, et al. (2006) The
ESCRT-III subunit hVps24 is required for degradation but not silencing of the
epidermal growth factor receptor. Mol Biol Cell 17: 2513–2523.
50. Malerod L, Stuffers S, Brech A, Stenmark H (2007) Vps22/EAP30 in ESCRT-II
mediates endosomal sorting of growth factor and chemokine receptors destined
for lysosomal degradation. Traffic 8: 1617–1629.
51. Perez M, Craven RC, de la Torre JC (2003) The small RING finger protein Z
drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad
Sci U S A 100: 12978–12983.
52. Kanagawa M, Saito F, Kunz S, Yoshida-Moriguchi T, Barresi R, et al. (2004)
Molecular recognition by LARGE is essential for expression of functional
dystroglycan. Cell 117: 953–964.
53. Scheuring S, Rohricht RA, Schoning-Burkhardt B, Beyer A, Muller S, et al.
(2001) Mammalian cells express two VPS4 proteins both of which are involved
in intracellular protein trafficking. J Mol Biol 312: 469–480.
54. Bishop N, Woodman P (2000) ATPase-defective mammalian VPS4 localizes to
aberrant endosomes and impairs cholesterol trafficking. Mol Biol Cell 11:
227–239.
55. Fujita H, Yamanaka M, Imamura K, Tanaka Y, Nara A, et al. (2003) A
dominant negative form of the AAA ATPase SKD1/VPS4 impairs membrane
trafficking out of endosomal/lysosomal compartments: class E vps phenotype in
mammalian cells. J Cell Sci 116: 401–414.
56. Urata S, Noda T, Kawaoka Y, Yokosawa H, Yasuda J (2006) Cellular factors
required for Lassa virus budding. J Virol 80: 4191–4195.
57. Kunz S, Sevilla N, Rojek JM, Oldstone MB (2004) Use of alternative receptors
different than alpha-dystroglycan by selected isolates of lymphocytic chorio-
meningitis virus. Virology 325: 432–445.
58. Pires R, Hartlieb B, Signor L, Schoehn G, Lata S, et al. (2009) A crescent-
shaped ALIX dimer targets ESCRT-III CHMP4 filaments. Structure 17:
843–856.
59. McCullough J, Fisher RD, Whitby FG, Sundquist WI, Hill CP (2008) ALIX-
CHMP4 interactions in the human ESCRT pathway. Proc Natl Acad Sci U S A
105: 7687–7691.
60. Abrami L, Lindsay M, Parton RG, Leppla SH, van der Goot FG (2004)
Membrane insertion of anthrax protective antigen and cytoplasmic delivery of
lethal factor occur at different stages of the endocytic pathway. J Cell Biol 166:
645–651.
61. Schmidt MH, Hoeller D, Yu J, Furnari FB, Cavenee WK, et al. (2004) Alix/
AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-
SETA/CIN85 complex. Mol Cell Biol 24: 8981–8993.
62. Chatellard-Causse C, Blot B, Cristina N, Torch S, Missotten M, et al. (2002)
Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to
endophilins and induces cytoplasmic vacuolization. J Biol Chem 277:
29108–29115.
63. Strack B, Calistri A, Craig S, Popova E, Gottlinger HG (2003) AIP1/ALIX is a
binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell
114: 689–699.
64. Chen C, Vincent O, Jin J, Weisz OA, Montelaro RC (2005) Functions of early
(AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia
virus budding. J Biol Chem 280: 40474–40480.
65. Zhai Q, Fisher RD, Chung HY, Myszka DG, Sundquist WI, et al. (2008)
Structural and functional studies of ALIX interactions with YPX(n)L late
domains of HIV-1 and EIAV. Nat Struct Mol Biol 15: 43–49.
66. Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, et al. (2000)
Immunosuppression and resultant viral persistence by specific viral targeting
of dendritic cells. J Exp Med 192: 1249–1260.
67. Smelt SC, Borrow P, Kunz S, Cao W, Tishon A, et al. (2001) Differences in
affinity of binding of lymphocytic choriomeningitis virus strains to the cellular
receptor alpha-dystroglycan correlate with viral tropism and disease kinetics.
J Virol 75: 448–457.
68. Rojek JM, Pasqual G, Sanchez AB, Nguyen NT, de la Torre JC, et al. (2010)
Targeting the proteolytic processing of the viral glycoprotein precursor is a
promising novel antiviral strategy against arenaviruses. J Virol 84: 573–584.
69. Cosset FL, Marianneau P, Verney G, Gallais F, Tordo N, et al. (2009)
Characterization of Lassa virus cell entry and neutralization with Lassa virus
pseudoparticles. J Virol 83: 3228–3237.
70. Puig-Kroger A, Serrano-Gomez D, Caparros E, Dominguez-Soto A, Relloso M,
et al. (2004) Regulated expression of the pathogen receptor dendritic cell-specific
intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1
human leukemic cells, monocytes, and macrophages. J Biol Chem 279:
25680–25688.
71. Kunz S, Rojek JM, Perez M, Spiropoulou CF, Oldstone MB (2005)
Characterization of the interaction of lassa fever virus with its cellular receptor
alpha-dystroglycan. J Virol 79: 5979–5987.
72. Reignier T, Oldenburg J, Noble B, Lamb E, Romanowski V, et al. (2006)
Receptor use by pathogenic arenaviruses. Virology 353: 111–120. Epub 2006
Jun 21.
73. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB (2001)
Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-
dystroglycan. J Cell Biol 155: 301–310.
74. Teng MN, Borrow P, Oldstone MB, de la Torre JC (1996) A single amino acid
change in the glycoprotein of lymphocytic choriomeningitis virus is associated
with the ability to cause growth hormone deficiency syndrome. J Virol 70:
8438–8443.
75. Trombetta ES, Mellman I (2005) Cell biology of antigen processing in vitro and
in vivo. Annu Rev Immunol 23: 975–1028.
76. Burgdorf S, Kurts C (2008) Endocytosis mechanisms and the cell biology of
antigen presentation. Curr Opin Immunol 20: 89–95.
77. Abrami L, Reig N, van der Goot FG (2005) Anthrax toxin: the long and winding
road that leads to the kill. Trends Microbiol 13: 72–78.
78. Khor R, McElroy LJ, Whittaker GR (2003) The ubiquitin-vacuolar protein
sorting system is selectively required during entry of influenza virus into host
cells. Traffic 4: 857–868.
Old World Arenaviruses Cell Entry
PLoS Pathogens | www.plospathogens.org 18 September 2011 | Volume 7 | Issue 9 | e100223279. Luyet PP, Falguieres T, Pons V, Pattnaik AK, Gruenberg J (2008) The ESCRT-
I subunit TSG101 controls endosome-to-cytosol release of viral RNA. Traffic 9:
2279–2290.
80. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, et al. (2003)
Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and
Lassa viruses. J Immunol 170: 2797–2801.
81. Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot MC, et al. (2004)
Lassa virus infection of human dendritic cells and macrophages is productive but
fails to activate cells. J Immunol 172: 2861–2869.
82. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, et al. (2006) Genetic analysis
of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev
Immunol 24: 353–389.
83. Buchmeier MJ, Lewicki HA, Tomori O, Oldstone MB (1981) Monoclonal
antibodies to lymphocytic choriomeningitis and pichinde viruses: generation,
characterization, and cross-reactivity with other arenaviruses. Virology 113:
73–85.
84. Kobayashi T, Stang E, Fang KS, de Moerloose P, Parton RG, et al. (1998) A
lipid associated with the antiphospholipid syndrome regulates endosome
structure and function. Nature 392: 193–197.
85. Lefrancois L, Lyles DS (1982) The interaction of antibody with the major surface
glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of
nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes.
Virology 121: 168–174.
86. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB (1984) Selection of
genetic variants of lymphocytic choriomeningitis virus in spleens of persistently
infected mice. Role in suppression of cytotoxic T lymphocyte response and viral
persistence. J Exp Med 160: 521–540.
87. Dutko FJ, Oldstone MB (1983) Genomic and biological variation among
commonly used lymphocytic choriomeningitis virus strains. J Gen Virol 64(Pt 8):
1689–1698.
88. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, et al. (1998) Identification
of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and
Lassa fever virus. Science 282: 2079–2081.
89. Benmerah A, Bayrou M, Cerf-Bensussan N, Dautry-Varsat A (1999) Inhibition
of clathrin-coated pit assembly by an Eps15 mutant. J Cell Sci 112(Pt 9):
1303–1311.
90. Sieczkarski SB, Whittaker GR (2002) Influenza virus can enter and infect cells in
the absence of clathrin-mediated endocytosis. J Virol 76: 10455–10464.
91. Sieczkarski SB, Whittaker GR (2003) Differential requirements of Rab5 and
Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4:
333–343.
92. Rojek JM, Lee AM, Nguyen N, Spiropoulou CF, Kunz S (2008) Site 1 protease
is required for proteolytic processing of the glycoproteins of the South American
hemorrhagic fever viruses Junin, Machupo, and Guanarito. J Virol 82:
6045–6051.
93. Bishop N, Horman A, Woodman P (2002) Mammalian class E vps proteins
recognize ubiquitin and act in the removal of endosomal protein-ubiquitin
conjugates. J Cell Biol 157: 91–101.
94. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(2Delta Delta C(T)) Method. Methods 25:
402–408.
95. Kim S, Kim H, Chang B, Ahn N, Hwang S, et al. (2006) Regulation of
transferrin recycling kinetics by PtdIns[4,5]P2 availability. FASEB J 20:
2399–2401.
96. Li L, Liao J, Ruland J, Mak TW, Cohen SN (2001) A TSG101/MDM2
regulatory loop modulates MDM2 degradation and MDM2/p53 feedback
control. Proc Natl Acad Sci U S A 98: 1619–1624.
Old World Arenaviruses Cell Entry
PLoS Pathogens | www.plospathogens.org 19 September 2011 | Volume 7 | Issue 9 | e1002232